data_2fqc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fqc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.22 -46.36 67.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.96 -44.26 96.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.72 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -57.24 -45.64 83.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.186 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.46 -43.64 98.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.87 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -62.3 -48.69 78.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.517 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.38 -13.93 60.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.247 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.29 78.86 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.963 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.43 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 22.8 pt -92.81 19.82 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.791 0.805 . . . . 0.0 109.695 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.22 -43.0 98.91 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.058 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -68.9 -18.11 64.07 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.513 -0.404 . . . . 0.0 110.581 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 16.9 tptp -83.58 -35.91 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.928 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -94.71 108.07 34.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.672 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.68 -48.16 22.77 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.917 2.411 . . . . 0.0 113.571 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 4.7 p90 -69.44 -21.66 63.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.554 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 95.4 m -122.43 53.61 1.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.7 p-80 . . . . . 0 N--CA 1.472 0.669 0 O-C-N 124.307 1.004 . . . . 0.0 112.462 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.5 m . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.76 -51.73 66.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.701 . . . . 0.0 109.736 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.26 -43.63 98.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.974 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -55.89 -48.04 76.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.047 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.6 m -65.69 -43.56 88.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 110.716 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -59.45 -44.17 93.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.186 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB1' HG12 ' A' ' 15' ' ' ILE . . . -88.53 -0.97 57.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 19.05 65.81 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.9 pt -92.15 20.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.771 0.796 . . . . 0.0 109.69 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -58.79 -45.77 94.43 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.802 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -67.22 -16.23 64.17 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.695 -0.297 . . . . 0.0 111.395 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.833 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -84.45 -37.35 21.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.232 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.75 109.76 34.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.46 -45.6 38.62 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.759 2.306 . . . . 0.0 113.302 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 7.3 p90 -70.71 -14.34 62.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.981 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 89.7 m -137.61 56.38 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.705 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 15.5 p-80 . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.843 0.83 . . . . 0.0 112.163 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.55 0.214 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -61.08 -47.22 87.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.306 0.574 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.22 -39.49 82.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.205 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -56.25 -47.66 78.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.719 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 m -64.87 -45.13 87.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.417 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -58.34 -43.4 88.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.057 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 1.18 55.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.81 59.49 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.598 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.496 HD13 HG21 ' A' ' 15' ' ' ILE . 15.3 pt -89.28 19.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.434 0.635 . . . . 0.0 110.367 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.18 -36.93 92.03 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.813 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -69.09 -27.34 65.51 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.384 -0.48 . . . . 0.0 110.589 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.47 -33.54 28.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.595 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.1 m-85 -88.59 111.61 45.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 111.664 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 17.6 Cg_endo -58.37 -45.45 30.68 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.991 2.461 . . . . 0.0 112.716 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -83.1 5.5 22.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.824 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.41 57.14 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.735 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 18.2 m-70 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 121.638 0.732 . . . . 0.0 111.335 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -60.61 -52.34 65.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.25 -43.15 87.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.991 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -56.5 -47.92 78.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.645 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.44 -39.57 92.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.22 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -62.91 -46.18 89.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.789 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.1 2.3 50.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.035 0.445 . . . . 0.0 111.356 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.72 61.44 Favored Glycine 0 CA--C 1.508 -0.399 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.477 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.1 pt -91.41 21.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.396 0.617 . . . . 0.0 110.116 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -59.59 -40.78 96.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.758 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -64.47 -30.6 71.63 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.358 -0.495 . . . . 0.0 110.668 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -73.51 -37.03 65.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.625 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.403 ' CE1' HD13 ' A' ' 15' ' ' ILE . 2.6 m-85 -88.29 112.85 52.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 111.856 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 35.6 Cg_exo -57.9 -46.14 28.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.17 2.58 . . . . 0.0 112.812 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -78.52 0.71 25.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.112 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.1 m -150.06 61.34 0.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.1 m-70 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.476 0.655 . . . . 0.0 112.263 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.802 0.334 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -64.6 -48.25 75.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.24 82.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -63.61 -41.59 98.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.321 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -59.68 -47.39 85.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.259 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.82 3.73 50.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.918 0.39 . . . . 0.0 111.741 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.02 25.6 72.13 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.973 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.74 HG21 ' HB3' ' A' ' 18' ' ' LYS . 9.3 mm -88.78 16.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.893 0.854 . . . . 0.0 109.346 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.37 -25.46 66.82 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.184 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -85.0 -22.92 28.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.731 0.301 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.74 ' HB3' HG21 ' A' ' 15' ' ' ILE . 54.0 tptt -90.33 -30.91 17.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.496 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -89.7 107.99 22.46 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 30.9 Cg_exo -61.27 -40.98 45.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.581 2.187 . . . . 0.0 111.844 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.54 -3.04 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.497 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.5 m -142.69 57.64 1.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 47.0 t-80 . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.666 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 88.5 m . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.855 0.36 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 2.4 m-80 -58.07 -50.37 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.403 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.29 -38.64 75.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.741 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.12 -47.24 72.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.984 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.92 -44.55 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 86.8 mtt180 -62.25 -44.07 97.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.979 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.48 1.6 48.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.419 . . . . 0.0 111.102 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.66 19.88 58.72 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.993 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 23.5 pt -90.15 14.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.739 . . . . 0.0 109.97 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.77 -33.54 87.17 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.506 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -66.36 -36.25 82.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HE3' ' HE1' ' A' ' 19' ' ' TYR . 38.9 ttpt -79.03 -30.84 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.183 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.505 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 3.0 m-30 -88.4 110.48 36.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.724 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 18.4 Cg_endo -58.5 -46.64 23.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.854 2.369 . . . . 0.0 112.693 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.3 p90 -75.66 -6.54 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.714 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.418 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 87.7 m -140.04 53.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.71 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 9.5 t60 . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.703 0.763 . . . . 0.0 111.449 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -66.66 -47.26 73.07 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.22 -30.41 64.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.14 -46.92 88.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.156 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -63.84 -41.48 97.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.184 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -60.36 -48.28 82.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.102 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.43 3.48 39.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.97 0.414 . . . . 0.0 111.321 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.45 19.93 60.61 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.799 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 17.9 pt -89.49 17.8 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.748 0.785 . . . . 0.0 109.972 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.66 -40.82 98.49 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.42 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -13.19 61.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.735 0.302 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -91.82 -36.33 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.832 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 m-85 -89.32 112.18 49.8 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 13.5 Cg_endo -56.85 -47.12 24.86 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.863 2.375 . . . . 0.0 112.927 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.6 p90 -75.47 -7.65 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.587 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 84.1 m -136.82 52.53 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.646 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 11.8 t-160 . . . . . 0 N--CA 1.465 0.283 0 O-C-N 124.036 0.835 . . . . 0.0 111.385 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 121.157 0.504 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -57.39 -50.39 73.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.709 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.9 -40.25 87.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.189 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.509 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.76 -48.74 72.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.636 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 m -65.3 -45.06 85.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -58.28 -44.28 88.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.345 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.2 3.06 50.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.89 18.83 57.86 Favored Glycine 0 CA--C 1.509 -0.292 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.57 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.509 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.4 pt -90.08 19.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.497 0.665 . . . . 0.0 109.933 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.46 -43.9 98.26 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.785 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -74.45 -7.42 52.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.793 0.33 . . . . 0.0 110.996 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HZ1' HG23 ' A' ' 15' ' ' ILE . 38.8 ttmt -91.09 -39.23 12.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.045 0.45 . . . . 0.0 109.797 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.407 ' HE1' ' HD2' ' A' ' 18' ' ' LYS . 2.2 m-30 -92.77 109.96 42.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.737 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.19 -43.73 50.23 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.753 2.302 . . . . 0.0 112.864 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.55 -0.38 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.014 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.5 m -147.13 51.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.688 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.771 0.796 . . . . 0.0 111.868 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.956 0.407 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.93 -51.02 69.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.561 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.64 -30.08 64.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.355 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.72 -47.01 88.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.806 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.7 m -64.77 -41.87 95.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -59.12 -44.61 92.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.793 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 3.62 49.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.97 20.96 58.39 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.618 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 13.4 pt -89.8 20.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.266 0.555 . . . . 0.0 110.366 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.24 -37.15 93.52 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.043 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -71.03 -23.05 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.408 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.701 ' HZ1' ' HB3' ' A' ' 18' ' ' LYS . 9.9 mtpm? -83.85 -34.4 24.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.691 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.6 112.35 51.25 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.998 0.428 . . . . 0.0 111.592 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.29 -45.58 33.98 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.972 2.448 . . . . 0.0 112.805 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 2.6 p90 -80.27 0.9 30.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.057 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 97.4 m -143.71 61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.7 m170 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.491 0.662 . . . . 0.0 112.172 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.65 -49.76 69.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.82 -30.92 68.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -61.22 -46.24 91.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.41 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -64.88 -42.37 94.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 12' ' ' ARG . 4.2 tmt_? -61.14 -47.7 85.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 0.98 43.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.961 0.41 . . . . 0.0 111.35 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.7 19.06 62.42 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.656 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.474 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.0 pt -89.98 17.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.642 0.734 . . . . 0.0 109.961 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.92 -39.53 98.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.415 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -70.31 -17.68 63.08 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.719 -0.283 . . . . 0.0 110.862 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -90.35 -33.02 16.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.509 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -88.35 112.89 52.68 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.69 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 -44.02 35.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.764 2.31 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -80.5 0.03 35.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.34 56.9 1.12 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t60 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.205 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -59.96 -46.19 90.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.777 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.83 -40.67 79.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.032 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -55.5 -46.14 77.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.468 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -65.01 -43.59 91.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -59.62 -46.75 88.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.097 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.72 1.28 43.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.968 0.413 . . . . 0.0 111.005 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.09 61.09 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.746 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.6 pt -89.11 20.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.233 0.539 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.19 -30.36 73.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.71 -23.58 56.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 4.3 mmmp? -88.3 -29.6 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.541 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.87 110.24 50.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.2 -43.84 32.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.75 2.3 . . . . 0.0 112.332 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.73 2.16 27.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.597 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -145.42 55.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 39.9 t60 . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 93.5 m . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.818 0.342 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.31 -55.52 33.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.37 -30.5 68.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.307 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . . . -60.76 -47.07 87.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.745 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.3 m -67.09 -41.17 86.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.432 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -59.69 -44.98 93.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.77 1.19 54.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.954 0.406 . . . . 0.0 111.099 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.04 63.31 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.614 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.42 20.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.457 0.646 . . . . 0.0 110.182 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.95 -31.89 80.13 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.837 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -74.11 -25.31 59.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 63.1 tttp -82.52 -34.53 27.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.549 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.08 110.47 40.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 111.678 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 31.1 Cg_exo -59.29 -43.69 39.17 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.91 2.406 . . . . 0.0 112.763 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -78.99 1.01 25.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.663 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.5 m -147.21 58.17 1.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t-160 . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.773 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.14 -50.6 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.69 -29.86 61.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.4 -46.01 89.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.033 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.23 -42.71 93.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.545 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -60.18 -47.9 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.199 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.29 2.83 42.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 111.388 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.6 21.98 61.1 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.695 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.0 pt -92.2 16.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.628 0.728 . . . . 0.0 109.758 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.17 -45.63 95.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.426 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -15.15 62.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.454 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 24.6 mmmt -91.14 -33.84 15.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.7 m-85 -88.84 113.86 57.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.0 110.991 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 12.0 Cg_endo -56.04 -46.64 29.59 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.1 2.533 . . . . 0.0 113.076 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -79.78 1.61 26.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.004 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -146.55 57.0 1.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.562 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 5.9 m170 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.527 0.679 . . . . 0.0 112.218 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 99.9 m . . . . . 0 CA--C 1.517 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -62.18 -44.91 95.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.459 0.647 . . . . 0.0 109.561 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.0 -37.74 72.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.91 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.557 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.35 -47.46 72.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.607 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -61.54 -45.23 95.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 109.984 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -60.45 -45.49 93.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.309 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.01 8.42 12.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.589 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.87 29.99 56.05 Favored Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.822 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.88 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 12.6 pt -99.61 22.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.315 0.579 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.29 -36.04 91.84 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.924 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -86.27 -15.83 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.164 0.507 . . . . 0.0 109.813 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.88 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -82.57 -39.86 21.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.811 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -96.75 111.68 58.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.237 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.58 -42.68 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.82 2.346 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -77.6 -6.0 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.7 m -133.14 55.05 1.92 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.548 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 59.8 t60 . . . . . 0 C--O 1.232 0.162 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 121.1 0.476 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -56.8 -56.45 21.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.087 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.93 -32.92 69.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.55 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -62.39 -45.53 92.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.543 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -65.41 -46.92 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -66.6 -37.64 85.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.24 -2.33 56.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 0.0 110.627 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.18 20.76 63.24 Favored Glycine 0 CA--C 1.508 -0.391 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.785 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.0 pt -93.41 16.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.663 0.744 . . . . 0.0 109.771 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.33 -42.66 98.92 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.783 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -62.69 -27.96 69.61 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.369 -0.489 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -80.27 -33.49 37.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -87.36 115.04 61.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 50.0 Cg_exo -56.46 -48.25 19.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.242 2.628 . . . . 0.0 113.294 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -79.28 2.32 21.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.4 m -150.0 58.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.689 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.5 m-70 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.56 0.695 . . . . 0.0 112.28 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 93.5 m . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.921 0.391 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -57.75 -55.14 38.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.455 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.17 -32.14 71.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.135 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.2 -46.25 90.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.299 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.0 -45.44 81.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 110.719 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.51 -44.32 96.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.22 1.34 45.07 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.03 19.71 59.39 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.607 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 14.3 pt -89.9 20.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.405 0.621 . . . . 0.0 110.199 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.93 -36.47 92.19 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.833 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -72.46 -23.84 61.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.923 0.392 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HD3' HG22 ' A' ' 15' ' ' ILE . 28.3 mtpp -83.24 -33.72 26.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -89.29 110.87 41.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 0.0 111.111 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 48.9 Cg_exo -56.66 -46.26 31.07 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.036 2.491 . . . . 0.0 112.802 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.77 -0.52 34.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.909 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.7 m -141.7 57.91 1.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.611 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 16.7 m170 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.581 0.705 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 91.7 m . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.102 0.477 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -61.56 -42.77 99.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.209 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.4 tp -75.91 -42.27 49.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.843 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -53.21 -45.84 68.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.63 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.3 m -66.14 -48.59 70.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 9' ' ' LEU . 19.6 ptp180 -64.51 -36.51 84.42 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.18 1.48 52.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.047 0.451 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.77 20.78 57.43 Favored Glycine 0 CA--C 1.509 -0.322 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.002 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.567 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.7 pt -94.28 17.87 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.656 0.741 . . . . 0.0 109.486 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.16 -41.22 98.07 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.343 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -74.46 -16.4 60.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -84.01 -37.42 22.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.066 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.455 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 m-85 -94.4 107.83 32.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 9.3 Cg_endo -52.87 -46.38 34.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.353 2.702 . . . . 0.0 113.715 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -68.21 -19.64 64.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.735 0.303 . . . . 0.0 111.675 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.6 m -128.55 55.77 1.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 20.3 p-80 . . . . . 0 N--CA 1.472 0.647 0 O-C-N 124.173 0.92 . . . . 0.0 111.815 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.734 0.302 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -58.17 -51.34 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.57 -30.95 61.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.007 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.79 -47.1 87.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.008 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.23 -42.23 84.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.538 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -59.83 -47.05 87.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.169 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 3.44 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.882 0.372 . . . . 0.0 111.258 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.43 21.29 59.88 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.689 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 10' ' ' ALA . 17.0 pt -91.59 16.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.612 0.72 . . . . 0.0 109.697 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.05 -43.46 99.41 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.267 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -17.46 64.54 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.745 -0.267 . . . . 0.0 111.433 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -90.75 -33.17 15.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.21 113.94 58.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.644 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.29 -46.24 26.12 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.952 2.435 . . . . 0.0 113.051 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -78.59 0.26 27.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 111.872 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -147.61 56.55 1.1 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.8 t60 . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.467 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 92.0 m . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.742 0.306 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -57.44 -55.1 39.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -71.86 -31.23 66.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.983 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 7' ' ' CYS . . . -58.2 -46.81 85.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.68 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 m -69.62 -38.12 77.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.223 0.535 . . . . 0.0 110.164 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -59.15 -45.82 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.527 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.37 7.12 47.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.824 0.345 . . . . 0.0 111.735 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.03 26.77 69.46 Favored Glycine 0 CA--C 1.511 -0.183 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.91 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.634 HG21 ' HB2' ' A' ' 18' ' ' LYS . 11.1 mm -88.49 10.75 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.959 0.885 . . . . 0.0 109.198 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -55.86 -41.46 83.84 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.649 -1.159 . . . . 0.0 112.113 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -18.16 63.59 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.487 -0.419 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HB2' HG21 ' A' ' 15' ' ' ILE . 99.1 mttt -91.17 -32.23 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -88.37 112.73 51.73 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 111.595 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 31.7 Cg_exo -58.63 -45.7 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.857 2.371 . . . . 0.0 112.261 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.95 -0.18 29.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 67.7 m -146.89 57.96 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.729 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.4 m-70 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 121.763 0.792 . . . . 0.0 111.445 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 6.2 m120 -62.37 -51.3 68.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.599 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.86 -31.07 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.315 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.48 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.617 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.0 m -64.37 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.794 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 38.1 mmt180 -62.0 -48.78 78.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.011 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.24 2.82 42.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 0.0 111.253 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.25 19.81 62.28 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.667 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.496 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 pt -89.92 20.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.506 0.67 . . . . 0.0 110.059 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.25 -41.07 99.39 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.765 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -71.09 -17.68 62.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 24.7 ttmm -83.57 -37.85 22.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.588 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.67 109.34 33.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 50.8 Cg_exo -56.07 -45.57 37.39 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.799 2.333 . . . . 0.0 113.104 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 6.1 p90 -73.49 -9.36 58.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 88.1 m -136.89 54.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.567 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 13.1 p80 . . . . . 0 N--CA 1.47 0.569 0 O-C-N 124.238 0.961 . . . . 0.0 112.527 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 50.7 t80 . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 52.9 Cg_endo -70.34 140.34 40.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.378 2.052 . . . . 0.0 111.639 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -70.82 115.57 37.22 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.43 137.1 67.71 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.53 2.154 . . . . 0.0 111.04 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 -55.99 -34.32 65.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.99 -39.54 85.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.4 m -58.83 -29.79 67.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.22 -46.36 67.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.96 -44.26 96.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.72 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -57.24 -45.64 83.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.186 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.46 -43.64 98.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.87 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -62.3 -48.69 78.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.517 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.38 -13.93 60.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.247 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.29 78.86 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.963 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.43 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 22.8 pt -92.81 19.82 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.791 0.805 . . . . 0.0 109.695 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.22 -43.0 98.91 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.058 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -68.9 -18.11 64.07 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.513 -0.404 . . . . 0.0 110.581 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 16.9 tptp -83.58 -35.91 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.928 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -94.71 108.07 34.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.672 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.68 -48.16 22.77 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.917 2.411 . . . . 0.0 113.571 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 4.7 p90 -69.44 -21.66 63.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.554 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 95.4 m -122.43 53.61 1.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.7 p-80 -65.89 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.307 1.004 . . . . 0.0 112.462 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -87.55 -166.92 1.72 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -59.53 146.71 39.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.634 -0.257 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.63 138.3 41.27 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.625 2.217 . . . . 0.0 112.433 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 3' ' ' ARG . 16.8 mmt180 -149.76 138.82 12.72 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 28.9 Cg_exo -61.33 142.28 95.41 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.818 2.345 . . . . 0.0 112.236 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.7 -19.19 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.704 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mt -62.95 -31.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.795 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.5 m -54.01 -31.02 49.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.771 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.76 -51.73 66.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.701 . . . . 0.0 109.736 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.26 -43.63 98.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.974 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -55.89 -48.04 76.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.047 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.6 m -65.69 -43.56 88.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 110.716 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -59.45 -44.17 93.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.186 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' HB1' HG12 ' A' ' 15' ' ' ILE . . . -88.53 -0.97 57.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 19.05 65.81 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.9 pt -92.15 20.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.771 0.796 . . . . 0.0 109.69 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -58.79 -45.77 94.43 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.802 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -67.22 -16.23 64.17 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.695 -0.297 . . . . 0.0 111.395 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.833 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -84.45 -37.35 21.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.232 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.75 109.76 34.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.46 -45.6 38.62 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.759 2.306 . . . . 0.0 113.302 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 7.3 p90 -70.71 -14.34 62.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.981 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 89.7 m -137.61 56.38 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.705 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 15.5 p-80 -67.97 56.37 0.07 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.843 0.83 . . . . 0.0 112.163 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 t -77.6 -168.99 1.32 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.08 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -72.99 -175.88 1.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.533 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.775 -0.193 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.512 ' HD1' ' H3 ' ' A' ' 1' ' ' PHE . 5.8 m-85 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.88 132.46 26.61 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.403 2.069 . . . . 0.0 111.795 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -67.27 130.58 93.54 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.003 0.43 . . . . 0.0 110.968 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.91 139.07 83.89 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.287 2.658 . . . . 0.0 112.269 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.81 -29.84 70.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mt -63.33 -34.94 70.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.048 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.8 m -53.96 -30.08 45.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -61.08 -47.22 87.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.306 0.574 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.22 -39.49 82.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.205 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -56.25 -47.66 78.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.719 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 m -64.87 -45.13 87.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.417 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -58.34 -43.4 88.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.057 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 1.18 55.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.81 59.49 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.598 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.496 HD13 HG21 ' A' ' 15' ' ' ILE . 15.3 pt -89.28 19.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.434 0.635 . . . . 0.0 110.367 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.18 -36.93 92.03 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.813 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -69.09 -27.34 65.51 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.384 -0.48 . . . . 0.0 110.589 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.47 -33.54 28.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.595 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.1 m-85 -88.59 111.61 45.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 111.664 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 17.6 Cg_endo -58.37 -45.45 30.68 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.991 2.461 . . . . 0.0 112.716 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -83.1 5.5 22.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.824 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.41 57.14 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.735 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 18.2 m-70 -73.77 54.23 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.638 0.732 . . . . 0.0 111.335 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.4 t -80.54 173.7 12.34 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.766 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -156.43 -24.44 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.068 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.397 -0.365 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.95 141.5 89.66 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.576 2.184 . . . . 0.0 111.966 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.566 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 14.3 tpt180 -152.99 120.34 3.04 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.301 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.566 ' HD2' ' HD2' ' A' ' 3' ' ' ARG . 24.0 Cg_exo -63.34 124.85 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.326 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -88.62 33.79 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.98 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.402 HD13 HG23 ' A' ' 6' ' ' ILE . 14.8 mm -71.35 -11.8 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.186 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.3 m -50.63 -29.29 10.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.146 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -60.61 -52.34 65.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.25 -43.15 87.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.991 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.501 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -56.5 -47.92 78.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.645 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.44 -39.57 92.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.22 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -62.91 -46.18 89.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.789 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.1 2.3 50.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.035 0.445 . . . . 0.0 111.356 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.72 61.44 Favored Glycine 0 CA--C 1.508 -0.399 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.477 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.1 pt -91.41 21.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.396 0.617 . . . . 0.0 110.116 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.712 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -59.59 -40.78 96.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.758 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -64.47 -30.6 71.63 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.358 -0.495 . . . . 0.0 110.668 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -73.51 -37.03 65.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.625 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.403 ' CE1' HD13 ' A' ' 15' ' ' ILE . 2.6 m-85 -88.29 112.85 52.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 111.856 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 35.6 Cg_exo -57.9 -46.14 28.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.17 2.58 . . . . 0.0 112.812 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -78.52 0.71 25.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.112 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.1 m -150.06 61.34 0.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.1 m-70 -70.89 55.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.476 0.655 . . . . 0.0 112.263 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.8 t -76.86 -168.25 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.663 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.8 mtm-85 -61.55 160.66 10.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.526 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.813 -0.176 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 19.3 p90 . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.76 133.25 26.95 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.44 2.093 . . . . 0.0 111.928 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -90.06 142.23 28.57 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.094 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.8 140.31 67.62 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.789 2.326 . . . . 0.0 111.51 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -49.87 -36.07 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.148 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.599 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 58.3 mt -72.58 -43.36 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.125 0.488 . . . . 0.0 110.959 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.64 -29.16 69.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.592 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -64.6 -48.25 75.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.24 82.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -63.61 -41.59 98.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.321 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -59.68 -47.39 85.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.259 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.82 3.73 50.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.918 0.39 . . . . 0.0 111.741 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.02 25.6 72.13 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.973 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.74 HG21 ' HB3' ' A' ' 18' ' ' LYS . 9.3 mm -88.78 16.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.893 0.854 . . . . 0.0 109.346 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.37 -25.46 66.82 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.184 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -85.0 -22.92 28.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.731 0.301 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.74 ' HB3' HG21 ' A' ' 15' ' ' ILE . 54.0 tptt -90.33 -30.91 17.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.496 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -89.7 107.99 22.46 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 30.9 Cg_exo -61.27 -40.98 45.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.581 2.187 . . . . 0.0 111.844 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.54 -3.04 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.497 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.5 m -142.69 57.64 1.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.603 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 47.0 t-80 -72.26 56.95 0.35 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.666 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 t -71.8 -175.29 1.35 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.259 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -155.59 133.05 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.514 -0.312 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.23 134.58 39.76 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.643 2.229 . . . . 0.0 111.821 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 46.3 mmm-85 -89.22 130.92 42.35 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.495 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 38.1 Cg_exo -60.0 138.07 79.81 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.067 2.511 . . . . 0.0 112.547 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 29.1 ptt-85 -61.31 -20.18 62.63 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.7 mm -59.8 -30.16 44.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.901 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 88.5 m -51.86 -30.64 24.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.967 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 2.4 m-80 -58.07 -50.37 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.403 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.29 -38.64 75.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.741 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.12 -47.24 72.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.984 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.92 -44.55 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 86.8 mtt180 -62.25 -44.07 97.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.979 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.48 1.6 48.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.419 . . . . 0.0 111.102 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.66 19.88 58.72 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.993 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 23.5 pt -90.15 14.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.739 . . . . 0.0 109.97 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.77 -33.54 87.17 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.506 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -66.36 -36.25 82.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HE3' ' HE1' ' A' ' 19' ' ' TYR . 38.9 ttpt -79.03 -30.84 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.183 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.505 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 3.0 m-30 -88.4 110.48 36.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.724 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 18.4 Cg_endo -58.5 -46.64 23.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.854 2.369 . . . . 0.0 112.693 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.3 p90 -75.66 -6.54 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.714 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.418 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 87.7 m -140.04 53.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.71 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 9.5 t60 -70.46 54.13 0.15 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.703 0.763 . . . . 0.0 111.449 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.3 t -78.93 178.28 8.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.444 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -73.71 -49.32 26.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.334 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.408 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 48.7 t80 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 60.8 Cg_endo -74.03 135.15 20.62 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.431 2.087 . . . . 0.0 111.697 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.535 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 14.3 ptm180 -170.95 159.68 5.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 3' ' ' ARG . 5.7 Cg_endo -48.69 136.14 27.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.509 2.806 . . . . 0.0 113.566 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -57.85 -27.45 63.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.642 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.639 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 40.0 mt -54.11 -35.91 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.055 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.1 m -54.07 -30.26 47.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -66.66 -47.26 73.07 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.3 pp -72.22 -30.41 64.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.14 -46.92 88.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.156 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -63.84 -41.48 97.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.184 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -60.36 -48.28 82.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.102 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.43 3.48 39.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.97 0.414 . . . . 0.0 111.321 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.45 19.93 60.61 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.799 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.482 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 17.9 pt -89.49 17.8 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.748 0.785 . . . . 0.0 109.972 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.66 -40.82 98.49 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.42 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -13.19 61.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.735 0.302 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -91.82 -36.33 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.832 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 m-85 -89.32 112.18 49.8 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 13.5 Cg_endo -56.85 -47.12 24.86 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.863 2.375 . . . . 0.0 112.927 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.6 p90 -75.47 -7.65 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.587 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 84.1 m -136.82 52.53 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.646 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 11.8 t-160 -69.11 55.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.036 0.835 . . . . 0.0 111.385 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -79.57 -178.04 6.13 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.448 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -73.4 -54.6 7.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.48 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.44 137.69 40.3 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 111.794 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 60.3 mtp85 -83.05 130.98 55.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.739 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 6' ' ' ILE . 35.6 Cg_exo -59.09 140.55 95.66 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.656 2.238 . . . . 0.0 111.132 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.71 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 68.1 ttt180 -77.11 39.98 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.455 0.645 . . . . 0.0 111.149 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' H ' ' C ' ' A' ' 4' ' ' PRO . 3.7 pt -72.65 -35.46 50.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -55.62 -27.79 51.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.116 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 5' ' ' ARG . 18.7 t30 -57.39 -50.39 73.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.709 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.9 -40.25 87.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.189 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.509 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.76 -48.74 72.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.636 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 m -65.3 -45.06 85.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -58.28 -44.28 88.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.345 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.2 3.06 50.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.89 18.83 57.86 Favored Glycine 0 CA--C 1.509 -0.292 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.57 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.509 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.4 pt -90.08 19.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.497 0.665 . . . . 0.0 109.933 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.46 -43.9 98.26 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.785 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -74.45 -7.42 52.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.793 0.33 . . . . 0.0 110.996 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HZ1' HG23 ' A' ' 15' ' ' ILE . 38.8 ttmt -91.09 -39.23 12.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.045 0.45 . . . . 0.0 109.797 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.407 ' HE1' ' HD2' ' A' ' 18' ' ' LYS . 2.2 m-30 -92.77 109.96 42.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.737 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.19 -43.73 50.23 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.753 2.302 . . . . 0.0 112.864 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.55 -0.38 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.014 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.5 m -147.13 51.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.688 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -68.66 54.42 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.771 0.796 . . . . 0.0 111.868 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.1 t -79.14 173.74 12.27 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.874 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -76.31 81.22 3.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.554 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 48.9 t80 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.19 143.14 12.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.943 2.428 . . . . 0.0 111.795 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.03 149.32 5.67 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 12.2 Cg_endo -56.57 148.61 62.92 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.985 2.457 . . . . 0.0 112.753 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -56.43 -27.25 56.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.457 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 42.4 mt -60.84 -36.9 74.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.435 ' SG ' ' HG2' ' A' ' 4' ' ' PRO . 86.3 m -57.67 -28.38 63.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.93 -51.02 69.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.561 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -72.64 -30.08 64.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.355 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.72 -47.01 88.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.806 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.7 m -64.77 -41.87 95.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -59.12 -44.61 92.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.793 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 3.62 49.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.97 20.96 58.39 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.618 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 13.4 pt -89.8 20.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.266 0.555 . . . . 0.0 110.366 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.24 -37.15 93.52 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.043 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -71.03 -23.05 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.408 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.701 ' HZ1' ' HB3' ' A' ' 18' ' ' LYS . 9.9 mtpm? -83.85 -34.4 24.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.691 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.6 112.35 51.25 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.998 0.428 . . . . 0.0 111.592 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.29 -45.58 33.98 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.972 2.448 . . . . 0.0 112.805 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 2.6 p90 -80.27 0.9 30.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.057 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 97.4 m -143.71 61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.7 m170 -69.38 53.07 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.491 0.662 . . . . 0.0 112.172 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.3 t -80.04 -173.17 3.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.491 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -81.11 173.65 12.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.314 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.74 -0.209 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.534 ' H2 ' ' HD1' ' A' ' 1' ' ' PHE . 5.6 m-85 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.58 142.64 59.57 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.602 2.202 . . . . 0.0 112.071 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.8 ptp180 -168.64 142.49 2.54 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.593 ' HD2' ' SG ' ' A' ' 7' ' ' CYS . 37.7 Cg_exo -57.36 146.99 80.11 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.854 2.37 . . . . 0.0 111.728 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -55.12 -33.88 63.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.442 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.657 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 46.2 mt -63.77 -37.54 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.833 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.593 ' SG ' ' HD2' ' A' ' 4' ' ' PRO . 96.7 m -55.11 -28.67 54.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.418 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.65 -49.76 69.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -69.82 -30.92 68.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -61.22 -46.24 91.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.41 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -64.88 -42.37 94.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 12' ' ' ARG . 4.2 tmt_? -61.14 -47.7 85.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 0.98 43.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.961 0.41 . . . . 0.0 111.35 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA2' ' HN2' ' A' ' 26' ' ' NH2 . . . 63.7 19.06 62.42 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.656 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.474 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.0 pt -89.98 17.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.642 0.734 . . . . 0.0 109.961 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.92 -39.53 98.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.415 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -70.31 -17.68 63.08 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.719 -0.283 . . . . 0.0 110.862 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -90.35 -33.02 16.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.509 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -88.35 112.89 52.68 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.69 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 -44.02 35.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.764 2.31 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -80.5 0.03 35.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.34 56.9 1.12 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t60 -70.21 52.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -76.36 -175.97 3.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.367 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -60.63 -57.71 11.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . 0.531 ' HN2' ' HA2' ' A' ' 14' ' ' GLY . . . . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.453 -0.34 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' HD1' ' H1 ' ' A' ' 1' ' ' PHE . 5.0 m-85 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.47 151.07 47.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.864 2.376 . . . . 0.0 111.927 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -165.66 152.89 9.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.84 144.5 35.08 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.189 2.593 . . . . 0.0 112.941 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -60.9 -24.68 66.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.95 -35.24 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.159 0.504 . . . . 0.0 110.096 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.2 -28.98 63.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.778 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -59.96 -46.19 90.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.777 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.83 -40.67 79.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.032 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -55.5 -46.14 77.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.468 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -65.01 -43.59 91.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -59.62 -46.75 88.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.097 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.72 1.28 43.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.968 0.413 . . . . 0.0 111.005 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.09 61.09 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.746 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.511 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.6 pt -89.11 20.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.233 0.539 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.19 -30.36 73.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.71 -23.58 56.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 4.3 mmmp? -88.3 -29.6 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.541 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.87 110.24 50.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.2 -43.84 32.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.75 2.3 . . . . 0.0 112.332 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.73 2.16 27.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.597 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -145.42 55.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 39.9 t60 -71.53 53.54 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.403 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -77.32 177.28 8.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.776 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -161.55 67.16 0.28 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.042 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.375 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.518 ' HD1' ' H1 ' ' A' ' 1' ' ' PHE . 5.7 m-85 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 17.2 Cg_exo -67.03 137.64 45.08 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.786 2.324 . . . . 0.0 111.89 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 ptm180 -165.64 138.64 3.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 23.0 Cg_exo -64.71 134.13 39.49 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.73 2.286 . . . . 0.0 112.121 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -68.2 -24.95 65.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.501 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.617 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 36.4 mm -59.24 -31.88 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 93.5 m -53.1 -29.09 28.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.413 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.31 -55.52 33.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -69.37 -30.5 68.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.307 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . . . -60.76 -47.07 87.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.745 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.3 m -67.09 -41.17 86.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.432 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -59.69 -44.98 93.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.77 1.19 54.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.954 0.406 . . . . 0.0 111.099 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.04 63.31 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.614 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.42 20.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.457 0.646 . . . . 0.0 110.182 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.95 -31.89 80.13 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.837 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -74.11 -25.31 59.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 63.1 tttp -82.52 -34.53 27.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.549 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.08 110.47 40.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 111.678 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 31.1 Cg_exo -59.29 -43.69 39.17 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.91 2.406 . . . . 0.0 112.763 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -78.99 1.01 25.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.663 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.5 m -147.21 58.17 1.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t-160 -68.78 54.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.773 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -78.66 -169.55 1.77 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.801 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -71.06 175.14 5.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.899 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 116.691 -0.231 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 53.0 t80 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 44.3 Cg_endo -69.5 137.31 35.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.364 2.043 . . . . 0.0 111.958 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.425 HH11 ' HB2' ' A' ' 7' ' ' CYS . 4.7 tmm_? -161.23 126.69 2.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.4 126.82 21.02 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.789 2.326 . . . . 0.0 112.97 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -69.42 -19.49 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.449 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.606 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 35.8 mt -64.79 -33.42 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.657 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' HB2' HH11 ' A' ' 3' ' ' ARG . 80.8 m -52.43 -30.31 28.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.367 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.14 -50.6 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -74.69 -29.86 61.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.157 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.4 -46.01 89.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.033 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.23 -42.71 93.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.545 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -60.18 -47.9 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.199 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.29 2.83 42.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 111.388 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.6 21.98 61.1 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.695 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.491 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.0 pt -92.2 16.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.628 0.728 . . . . 0.0 109.758 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.17 -45.63 95.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.426 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -15.15 62.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.454 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 24.6 mmmt -91.14 -33.84 15.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.7 m-85 -88.84 113.86 57.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.0 110.991 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 12.0 Cg_endo -56.04 -46.64 29.59 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.1 2.533 . . . . 0.0 113.076 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -79.78 1.61 26.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.004 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -146.55 57.0 1.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.562 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 5.9 m170 -69.53 53.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.527 0.679 . . . . 0.0 112.218 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.1 t -83.15 -178.64 7.17 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.138 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.6 -101.27 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.558 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.398 0 O-C-N 122.321 -0.237 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.441 ' H2 ' ' HD1' ' A' ' 1' ' ' PHE . 5.9 m-85 . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.49 149.81 84.35 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.736 2.291 . . . . 0.0 112.118 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -148.0 136.38 11.3 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.99 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.15 132.45 49.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.914 2.409 . . . . 0.0 112.665 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -65.14 -24.65 67.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -63.69 -34.94 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.582 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 99.9 m -54.95 -30.37 58.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -62.18 -44.91 95.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.459 0.647 . . . . 0.0 109.561 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.0 -37.74 72.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.91 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.557 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.35 -47.46 72.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.607 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -61.54 -45.23 95.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 109.984 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -60.45 -45.49 93.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.309 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.01 8.42 12.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.589 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.87 29.99 56.05 Favored Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.822 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.88 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 12.6 pt -99.61 22.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.315 0.579 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.29 -36.04 91.84 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.924 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -86.27 -15.83 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.164 0.507 . . . . 0.0 109.813 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.88 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -82.57 -39.86 21.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.811 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -96.75 111.68 58.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.237 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.58 -42.68 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.82 2.346 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -77.6 -6.0 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.7 m -133.14 55.05 1.92 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.548 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 59.8 t60 -71.25 54.68 0.2 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.076 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 t -74.0 176.0 6.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.169 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -68.84 103.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 116.445 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.453 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 41.1 t80 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.453 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 80.0 Cg_endo -77.97 178.58 7.42 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.759 2.306 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -163.88 146.22 7.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.9 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 140.0 85.49 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.651 2.234 . . . . 0.0 112.3 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.13 -17.65 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.273 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 34.5 mm -60.91 -33.03 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.782 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -53.85 -29.65 42.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.037 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -56.8 -56.45 21.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.087 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 3.9 pp -70.93 -32.92 69.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.55 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -62.39 -45.53 92.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.543 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -65.41 -46.92 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.0 ptp180 -66.6 -37.64 85.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.24 -2.33 56.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 0.0 110.627 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.18 20.76 63.24 Favored Glycine 0 CA--C 1.508 -0.391 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.785 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.0 pt -93.41 16.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.663 0.744 . . . . 0.0 109.771 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.33 -42.66 98.92 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.783 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -62.69 -27.96 69.61 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.369 -0.489 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -80.27 -33.49 37.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -87.36 115.04 61.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.421 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 50.0 Cg_exo -56.46 -48.25 19.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.242 2.628 . . . . 0.0 113.294 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -79.28 2.32 21.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.4 m -150.0 58.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.689 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.5 m-70 -70.02 53.24 0.13 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.56 0.695 . . . . 0.0 112.28 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.8 t -77.19 -170.25 1.64 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -67.49 173.14 4.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.787 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.695 -0.229 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.458 ' H2 ' ' HD1' ' A' ' 1' ' ' PHE . 8.0 m-85 . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 14.5 Cg_exo -68.66 137.94 40.19 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.935 2.423 . . . . 0.0 111.631 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -87.41 127.34 59.12 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.16 145.76 63.41 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.79 2.327 . . . . 0.0 110.891 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -50.48 -35.34 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.782 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 49.3 mm -74.27 -43.7 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 110.788 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 93.5 m -60.94 -28.26 68.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -57.75 -55.14 38.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.455 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -69.17 -32.14 71.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.135 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.2 -46.25 90.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.299 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.0 -45.44 81.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 110.719 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.51 -44.32 96.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.22 1.34 45.07 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.03 19.71 59.39 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.607 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 14.3 pt -89.9 20.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.405 0.621 . . . . 0.0 110.199 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.93 -36.47 92.19 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.833 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -72.46 -23.84 61.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.923 0.392 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HD3' HG22 ' A' ' 15' ' ' ILE . 28.3 mtpp -83.24 -33.72 26.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -89.29 110.87 41.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 0.0 111.111 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 48.9 Cg_exo -56.66 -46.26 31.07 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.036 2.491 . . . . 0.0 112.802 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.77 -0.52 34.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.909 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.7 m -141.7 57.91 1.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.611 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 16.7 m170 -69.83 52.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.581 0.705 . . . . 0.0 111.797 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.4 t -78.19 -179.04 5.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.643 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.33 154.05 11.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.09 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 116.737 -0.21 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.88 132.57 20.21 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.624 2.216 . . . . 0.0 111.595 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -78.87 143.62 62.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.759 0.314 . . . . 0.0 110.658 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.32 139.08 63.84 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.732 2.288 . . . . 0.0 112.279 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -65.99 -15.07 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.0 mt -59.83 -33.75 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.369 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 10' ' ' ALA . 91.7 m -56.23 -30.67 62.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.568 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -61.56 -42.77 99.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.209 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.4 tp -75.91 -42.27 49.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.843 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -53.21 -45.84 68.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.63 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.3 m -66.14 -48.59 70.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 9' ' ' LEU . 19.6 ptp180 -64.51 -36.51 84.42 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.18 1.48 52.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.047 0.451 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.77 20.78 57.43 Favored Glycine 0 CA--C 1.509 -0.322 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.002 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.567 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.7 pt -94.28 17.87 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.656 0.741 . . . . 0.0 109.486 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.16 -41.22 98.07 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.343 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -74.46 -16.4 60.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -84.01 -37.42 22.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.066 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.455 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 m-85 -94.4 107.83 32.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 9.3 Cg_endo -52.87 -46.38 34.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.353 2.702 . . . . 0.0 113.715 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -68.21 -19.64 64.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.735 0.303 . . . . 0.0 111.675 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.6 m -128.55 55.77 1.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 20.3 p-80 -68.05 54.72 0.07 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.173 0.92 . . . . 0.0 111.815 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.0 -175.99 4.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.819 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -66.26 -58.01 6.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.714 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.445 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 38.5 t80 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 5.8 Cg_exo -77.46 68.54 7.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.127 2.551 . . . . 0.0 111.911 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.454 ' O ' ' HD2' ' A' ' 3' ' ' ARG . 7.3 ppt_? -72.34 145.18 87.74 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.116 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.82 152.41 35.66 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.459 2.773 . . . . 0.0 113.66 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -62.6 -25.3 68.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.879 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.617 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 38.7 mt -60.49 -31.79 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.078 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.436 ' HB2' ' HD3' ' A' ' 3' ' ' ARG . 87.2 m -51.92 -28.98 18.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -58.17 -51.34 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -74.57 -30.95 61.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.007 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.79 -47.1 87.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.008 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.23 -42.23 84.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.538 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -59.83 -47.05 87.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.169 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 3.44 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.882 0.372 . . . . 0.0 111.258 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.43 21.29 59.88 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.689 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 10' ' ' ALA . 17.0 pt -91.59 16.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.612 0.72 . . . . 0.0 109.697 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.05 -43.46 99.41 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.267 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -17.46 64.54 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.745 -0.267 . . . . 0.0 111.433 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -90.75 -33.17 15.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -89.21 113.94 58.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.644 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.29 -46.24 26.12 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.952 2.435 . . . . 0.0 113.051 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -78.59 0.26 27.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 111.872 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -147.61 56.55 1.1 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.616 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.8 t60 -69.96 52.63 0.12 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.774 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -78.03 -175.76 4.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.328 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -78.19 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.687 -0.233 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.0 t80 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.18 138.61 33.73 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.763 2.308 . . . . 0.0 111.31 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -136.54 135.88 21.2 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.28 167.86 22.59 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.197 2.598 . . . . 0.0 112.349 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -68.91 -23.05 64.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.562 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 21.6 mt -49.59 -26.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.814 0.846 . . . . 0.0 112.116 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.467 ' HA ' ' HB1' ' A' ' 10' ' ' ALA . 92.0 m -51.15 -27.93 9.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -57.44 -55.1 39.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -71.86 -31.23 66.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.983 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 7' ' ' CYS . . . -58.2 -46.81 85.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.68 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 m -69.62 -38.12 77.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.223 0.535 . . . . 0.0 110.164 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -59.15 -45.82 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.527 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.37 7.12 47.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.824 0.345 . . . . 0.0 111.735 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.03 26.77 69.46 Favored Glycine 0 CA--C 1.511 -0.183 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.91 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.634 HG21 ' HB2' ' A' ' 18' ' ' LYS . 11.1 mm -88.49 10.75 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.959 0.885 . . . . 0.0 109.198 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -55.86 -41.46 83.84 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.649 -1.159 . . . . 0.0 112.113 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -18.16 63.59 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.487 -0.419 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HB2' HG21 ' A' ' 15' ' ' ILE . 99.1 mttt -91.17 -32.23 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -88.37 112.73 51.73 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 111.595 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 31.7 Cg_exo -58.63 -45.7 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.857 2.371 . . . . 0.0 112.261 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.95 -0.18 29.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 67.7 m -146.89 57.96 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.729 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.4 m-70 -72.92 55.78 0.41 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.763 0.792 . . . . 0.0 111.445 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.55 178.52 7.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.726 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -66.09 120.05 12.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.766 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 116.346 -0.388 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 154.01 55.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.907 2.405 . . . . 0.0 112.57 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -124.02 133.49 24.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.897 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 23.8 Cg_exo -62.62 146.0 95.28 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.889 2.392 . . . . 0.0 112.19 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -61.81 -9.7 7.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.624 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.557 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 52.3 mt -63.6 -35.79 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.263 0.554 . . . . 0.0 109.721 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m -59.92 -29.44 68.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.249 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 6.2 m120 -62.37 -51.3 68.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.599 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -71.86 -31.07 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.315 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.48 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.617 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.0 m -64.37 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.794 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 38.1 mmt180 -62.0 -48.78 78.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.011 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.24 2.82 42.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 0.0 111.253 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.25 19.81 62.28 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.667 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.496 HG21 HD13 ' A' ' 15' ' ' ILE . 18.7 pt -89.92 20.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.506 0.67 . . . . 0.0 110.059 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.25 -41.07 99.39 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.765 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -71.09 -17.68 62.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 24.7 ttmm -83.57 -37.85 22.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.588 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.67 109.34 33.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 50.8 Cg_exo -56.07 -45.57 37.39 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.799 2.333 . . . . 0.0 113.104 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 6.1 p90 -73.49 -9.36 58.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 88.1 m -136.89 54.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.567 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 13.1 p80 -66.04 55.77 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.238 0.961 . . . . 0.0 112.527 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.1 t -82.02 -171.8 3.59 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.246 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -68.34 154.77 41.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.488 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.22 -46.36 67.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.96 -44.26 96.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.72 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -57.24 -45.64 83.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.186 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.46 -43.64 98.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.87 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -62.3 -48.69 78.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.517 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.38 -13.93 60.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.247 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.29 78.86 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.963 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 22.8 pt -92.81 19.82 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.791 0.805 . . . . 0.0 109.695 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.22 -43.0 98.91 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.058 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -68.9 -18.11 64.07 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.513 -0.404 . . . . 0.0 110.581 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 16.9 tptp -83.58 -35.91 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.928 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -94.71 108.07 34.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.672 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.68 -48.16 22.77 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.917 2.411 . . . . 0.0 113.571 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 4.7 p90 -69.44 -21.66 63.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.554 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 95.4 m -122.43 53.61 1.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.7 p-80 . . . . . 0 N--CA 1.472 0.669 0 O-C-N 124.307 1.004 . . . . 0.0 112.462 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.5 m . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.76 -51.73 66.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.701 . . . . 0.0 109.736 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.26 -43.63 98.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.974 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -55.89 -48.04 76.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.047 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.6 m -65.69 -43.56 88.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 110.716 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -59.45 -44.17 93.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.186 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 -0.97 57.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 19.05 65.81 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.9 pt -92.15 20.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.771 0.796 . . . . 0.0 109.69 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -58.79 -45.77 94.43 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.802 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -67.22 -16.23 64.17 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.695 -0.297 . . . . 0.0 111.395 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.851 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -84.45 -37.35 21.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.232 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.75 109.76 34.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.46 -45.6 38.62 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.759 2.306 . . . . 0.0 113.302 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 7.3 p90 -70.71 -14.34 62.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.981 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 89.7 m -137.61 56.38 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 15.5 p-80 . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.843 0.83 . . . . 0.0 112.163 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.55 0.214 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -61.08 -47.22 87.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.306 0.574 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.22 -39.49 82.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.205 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -56.25 -47.66 78.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.719 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 m -64.87 -45.13 87.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.417 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -58.34 -43.4 88.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.057 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 1.18 55.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.81 59.49 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.598 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.28 19.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.434 0.635 . . . . 0.0 110.367 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.18 -36.93 92.03 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.813 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -69.09 -27.34 65.51 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.384 -0.48 . . . . 0.0 110.589 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.47 -33.54 28.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.595 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.1 m-85 -88.59 111.61 45.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 111.664 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 17.6 Cg_endo -58.37 -45.45 30.68 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.991 2.461 . . . . 0.0 112.716 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -83.1 5.5 22.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.824 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.41 57.14 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.744 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 18.2 m-70 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 121.638 0.732 . . . . 0.0 111.335 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -60.61 -52.34 65.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.25 -43.15 87.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.991 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -56.5 -47.92 78.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.645 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.44 -39.57 92.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.22 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -62.91 -46.18 89.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.789 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.1 2.3 50.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.035 0.445 . . . . 0.0 111.356 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.72 61.44 Favored Glycine 0 CA--C 1.508 -0.399 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.477 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.1 pt -91.41 21.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.396 0.617 . . . . 0.0 110.116 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -59.59 -40.78 96.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.758 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -64.47 -30.6 71.63 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.358 -0.495 . . . . 0.0 110.668 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -73.51 -37.03 65.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.625 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.29 112.85 52.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 111.856 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 35.6 Cg_exo -57.9 -46.14 28.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.17 2.58 . . . . 0.0 112.812 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -78.52 0.71 25.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.112 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.1 m -150.06 61.34 0.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.724 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.1 m-70 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.476 0.655 . . . . 0.0 112.263 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.802 0.334 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -64.6 -48.25 75.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.24 82.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -63.61 -41.59 98.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.321 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -59.68 -47.39 85.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.259 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -88.82 3.73 50.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.918 0.39 . . . . 0.0 111.741 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.02 25.6 72.13 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.973 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 18' ' ' LYS . 9.3 mm -88.78 16.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.893 0.854 . . . . 0.0 109.346 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.37 -25.46 66.82 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.184 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -85.0 -22.92 28.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.731 0.301 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 15' ' ' ILE . 54.0 tptt -90.33 -30.91 17.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.496 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -89.7 107.99 22.46 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 30.9 Cg_exo -61.27 -40.98 45.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.581 2.187 . . . . 0.0 111.844 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.54 -3.04 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.497 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.5 m -142.69 57.64 1.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 47.0 t-80 . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.666 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.855 0.36 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 2.4 m-80 -58.07 -50.37 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.403 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 3.3 mt -70.29 -38.64 75.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.535 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.12 -47.24 72.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.984 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.92 -44.55 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 86.8 mtt180 -62.25 -44.07 97.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.979 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.48 1.6 48.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.419 . . . . 0.0 111.102 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.66 19.88 58.72 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.993 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.535 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 23.5 pt -90.15 14.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.739 . . . . 0.0 109.97 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.77 -33.54 87.17 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.506 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -66.36 -36.25 82.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE3' ' HE1' ' A' ' 19' ' ' TYR . 38.9 ttpt -79.03 -30.84 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.183 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 3.0 m-30 -88.4 110.48 36.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.724 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 18.4 Cg_endo -58.5 -46.64 23.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.854 2.369 . . . . 0.0 112.693 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.419 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.3 p90 -75.66 -6.54 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.714 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 87.7 m -140.04 53.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 9.5 t60 . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.703 0.763 . . . . 0.0 111.449 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -66.66 -47.26 73.07 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.22 -30.41 64.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.14 -46.92 88.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.156 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -63.84 -41.48 97.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.184 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -60.36 -48.28 82.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.102 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.43 3.48 39.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.97 0.414 . . . . 0.0 111.321 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.45 19.93 60.61 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.799 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 17.9 pt -89.49 17.8 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.748 0.785 . . . . 0.0 109.972 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.66 -40.82 98.49 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.42 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -13.19 61.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.735 0.302 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -91.82 -36.33 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.832 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 m-85 -89.32 112.18 49.8 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 13.5 Cg_endo -56.85 -47.12 24.86 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.863 2.375 . . . . 0.0 112.927 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.472 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.6 p90 -75.47 -7.65 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.587 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.472 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 84.1 m -136.82 52.53 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 O-C-N 124.036 0.835 . . . . 0.0 111.385 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 121.157 0.504 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -57.39 -50.39 73.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.709 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.9 -40.25 87.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.189 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.76 -48.74 72.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.636 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 m -65.3 -45.06 85.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -58.28 -44.28 88.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.345 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.2 3.06 50.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.89 18.83 57.86 Favored Glycine 0 CA--C 1.509 -0.292 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.57 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.4 pt -90.08 19.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.497 0.665 . . . . 0.0 109.933 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.46 -43.9 98.26 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.785 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -74.45 -7.42 52.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.793 0.33 . . . . 0.0 110.996 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HD2' ' HE1' ' A' ' 19' ' ' TYR . 38.8 ttmt -91.09 -39.23 12.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.045 0.45 . . . . 0.0 109.797 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' HE1' ' HD2' ' A' ' 18' ' ' LYS . 2.2 m-30 -92.77 109.96 42.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.737 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.19 -43.73 50.23 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.753 2.302 . . . . 0.0 112.864 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.55 -0.38 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.014 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.5 m -147.13 51.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.697 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.771 0.796 . . . . 0.0 111.868 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.956 0.407 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.93 -51.02 69.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.561 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.64 -30.08 64.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.355 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.72 -47.01 88.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.806 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.7 m -64.77 -41.87 95.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -59.12 -44.61 92.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.793 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 3.62 49.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.97 20.96 58.39 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.618 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 13.4 pt -89.8 20.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.266 0.555 . . . . 0.0 110.366 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.24 -37.15 93.52 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.043 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -71.03 -23.05 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.408 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 9.9 mtpm? -83.85 -34.4 24.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.691 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.6 112.35 51.25 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.998 0.428 . . . . 0.0 111.592 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.29 -45.58 33.98 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.972 2.448 . . . . 0.0 112.805 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 2.6 p90 -80.27 0.9 30.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.057 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 97.4 m -143.71 61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.7 m170 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.491 0.662 . . . . 0.0 112.172 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.65 -49.76 69.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.82 -30.92 68.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -61.22 -46.24 91.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.41 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -64.88 -42.37 94.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 4.2 tmt_? -61.14 -47.7 85.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 0.98 43.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.961 0.41 . . . . 0.0 111.35 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.7 19.06 62.42 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.656 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.0 pt -89.98 17.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.642 0.734 . . . . 0.0 109.961 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.92 -39.53 98.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.415 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -70.31 -17.68 63.08 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.719 -0.283 . . . . 0.0 110.862 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -90.35 -33.02 16.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.509 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -88.35 112.89 52.68 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.69 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 -44.02 35.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.764 2.31 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -80.5 0.03 35.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.34 56.9 1.12 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t60 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.205 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -59.96 -46.19 90.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.777 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.83 -40.67 79.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.032 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -55.5 -46.14 77.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.468 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -65.01 -43.59 91.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -59.62 -46.75 88.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.097 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.72 1.28 43.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.968 0.413 . . . . 0.0 111.005 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.09 61.09 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.746 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.6 pt -89.11 20.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.233 0.539 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.19 -30.36 73.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.71 -23.58 56.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 4.3 mmmp? -88.3 -29.6 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.541 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.87 110.24 50.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.2 -43.84 32.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.75 2.3 . . . . 0.0 112.332 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.73 2.16 27.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.597 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -145.42 55.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.607 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 39.9 t60 . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.818 0.342 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.31 -55.52 33.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.37 -30.5 68.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.307 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -60.76 -47.07 87.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.745 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.3 m -67.09 -41.17 86.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.432 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -59.69 -44.98 93.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.77 1.19 54.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.954 0.406 . . . . 0.0 111.099 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.04 63.31 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.614 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.42 20.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.457 0.646 . . . . 0.0 110.182 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.95 -31.89 80.13 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.837 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -74.11 -25.31 59.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 63.1 tttp -82.52 -34.53 27.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.549 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.08 110.47 40.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 111.678 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 31.1 Cg_exo -59.29 -43.69 39.17 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.91 2.406 . . . . 0.0 112.763 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -78.99 1.01 25.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.663 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.5 m -147.21 58.17 1.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t-160 . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.773 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.14 -50.6 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.69 -29.86 61.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.509 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.4 -46.01 89.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.033 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.23 -42.71 93.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.545 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -60.18 -47.9 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.199 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.29 2.83 42.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 111.388 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.6 21.98 61.1 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.695 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.0 pt -92.2 16.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.628 0.728 . . . . 0.0 109.758 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.17 -45.63 95.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.426 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -15.15 62.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.454 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 24.6 mmmt -91.14 -33.84 15.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.7 m-85 -88.84 113.86 57.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.0 110.991 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 12.0 Cg_endo -56.04 -46.64 29.59 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.1 2.533 . . . . 0.0 113.076 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -79.78 1.61 26.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.004 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -146.55 57.0 1.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 5.9 m170 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.527 0.679 . . . . 0.0 112.218 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.9 m . . . . . 0 CA--C 1.517 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -62.18 -44.91 95.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.459 0.647 . . . . 0.0 109.561 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.0 -37.74 72.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.91 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.569 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.35 -47.46 72.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.607 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -61.54 -45.23 95.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 109.984 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -60.45 -45.49 93.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.309 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.01 8.42 12.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.589 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.87 29.99 56.05 Favored Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.822 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.853 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 12.6 pt -99.61 22.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.315 0.579 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.29 -36.04 91.84 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.924 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -86.27 -15.83 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.164 0.507 . . . . 0.0 109.813 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.853 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -82.57 -39.86 21.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.811 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -96.75 111.68 58.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.237 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.58 -42.68 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.82 2.346 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -77.6 -6.0 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.7 m -133.14 55.05 1.92 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 59.8 t60 . . . . . 0 C--O 1.232 0.162 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 121.1 0.476 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -56.8 -56.45 21.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.087 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 3.9 pp -70.93 -32.92 69.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.55 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -62.39 -45.53 92.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.543 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -65.41 -46.92 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 9' ' ' LEU . 20.0 ptp180 -66.6 -37.64 85.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.24 -2.33 56.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 0.0 110.627 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.18 20.76 63.24 Favored Glycine 0 CA--C 1.508 -0.391 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.785 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.0 pt -93.41 16.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.663 0.744 . . . . 0.0 109.771 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.33 -42.66 98.92 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.783 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -62.69 -27.96 69.61 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.369 -0.489 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -80.27 -33.49 37.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -87.36 115.04 61.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 50.0 Cg_exo -56.46 -48.25 19.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.242 2.628 . . . . 0.0 113.294 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -79.28 2.32 21.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.4 m -150.0 58.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.5 m-70 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.56 0.695 . . . . 0.0 112.28 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.921 0.391 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -57.75 -55.14 38.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.455 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.17 -32.14 71.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.135 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.2 -46.25 90.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.299 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.0 -45.44 81.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 110.719 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.51 -44.32 96.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.22 1.34 45.07 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.03 19.71 59.39 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.607 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 14.3 pt -89.9 20.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.405 0.621 . . . . 0.0 110.199 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.93 -36.47 92.19 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.833 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -72.46 -23.84 61.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.923 0.392 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 28.3 mtpp -83.24 -33.72 26.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -89.29 110.87 41.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 0.0 111.111 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 48.9 Cg_exo -56.66 -46.26 31.07 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.036 2.491 . . . . 0.0 112.802 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.77 -0.52 34.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.909 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.7 m -141.7 57.91 1.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 16.7 m170 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.581 0.705 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.102 0.477 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.56 -42.77 99.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.209 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.4 tp -75.91 -42.27 49.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.843 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -53.21 -45.84 68.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.63 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.3 m -66.14 -48.59 70.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' LEU . 19.6 ptp180 -64.51 -36.51 84.42 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.18 1.48 52.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.047 0.451 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.77 20.78 57.43 Favored Glycine 0 CA--C 1.509 -0.322 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.002 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.7 pt -94.28 17.87 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.656 0.741 . . . . 0.0 109.486 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.16 -41.22 98.07 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.343 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -74.46 -16.4 60.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 15' ' ' ILE . 56.7 mtpt -84.01 -37.42 22.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.066 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 m-85 -94.4 107.83 32.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 9.3 Cg_endo -52.87 -46.38 34.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.353 2.702 . . . . 0.0 113.715 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -68.21 -19.64 64.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.735 0.303 . . . . 0.0 111.675 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.6 m -128.55 55.77 1.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.648 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 20.3 p-80 . . . . . 0 N--CA 1.472 0.647 0 O-C-N 124.173 0.92 . . . . 0.0 111.815 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.734 0.302 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -58.17 -51.34 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.57 -30.95 61.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.007 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.79 -47.1 87.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.008 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.23 -42.23 84.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.538 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -59.83 -47.05 87.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.169 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 3.44 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.882 0.372 . . . . 0.0 111.258 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.43 21.29 59.88 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.689 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 10' ' ' ALA . 17.0 pt -91.59 16.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.612 0.72 . . . . 0.0 109.697 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.05 -43.46 99.41 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.267 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -17.46 64.54 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.745 -0.267 . . . . 0.0 111.433 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -90.75 -33.17 15.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.2 m-85 -89.21 113.94 58.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.644 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 17.7 Cg_endo -58.29 -46.24 26.12 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.952 2.435 . . . . 0.0 113.051 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -78.59 0.26 27.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 111.872 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -147.61 56.55 1.1 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.629 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.8 t60 . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.742 0.306 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -57.44 -55.1 39.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -71.86 -31.23 66.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.983 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -46.81 85.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.68 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 m -69.62 -38.12 77.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.223 0.535 . . . . 0.0 110.164 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -59.15 -45.82 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.527 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -97.37 7.12 47.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.824 0.345 . . . . 0.0 111.735 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.03 26.77 69.46 Favored Glycine 0 CA--C 1.511 -0.183 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.91 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.666 HG23 ' HD2' ' A' ' 18' ' ' LYS . 11.1 mm -88.49 10.75 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.959 0.885 . . . . 0.0 109.198 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -55.86 -41.46 83.84 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.649 -1.159 . . . . 0.0 112.113 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -18.16 63.59 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.487 -0.419 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HD2' HG23 ' A' ' 15' ' ' ILE . 99.1 mttt -91.17 -32.23 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -88.37 112.73 51.73 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 111.595 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 31.7 Cg_exo -58.63 -45.7 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.857 2.371 . . . . 0.0 112.261 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.95 -0.18 29.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 67.7 m -146.89 57.96 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.736 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.4 m-70 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 121.763 0.792 . . . . 0.0 111.445 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 74.5 m-20 -62.37 -51.3 68.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.599 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.86 -31.07 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.315 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.48 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.617 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.0 m -64.37 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.794 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 38.1 mmt180 -62.0 -48.78 78.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.011 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.24 2.82 42.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 0.0 111.253 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.25 19.81 62.28 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.667 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 10' ' ' ALA . 18.7 pt -89.92 20.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.506 0.67 . . . . 0.0 110.059 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.25 -41.07 99.39 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.765 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -71.09 -17.68 62.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 24.7 ttmm -83.57 -37.85 22.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.588 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.67 109.34 33.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 50.8 Cg_exo -56.07 -45.57 37.39 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.799 2.333 . . . . 0.0 113.104 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 6.1 p90 -73.49 -9.36 58.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 88.1 m -136.89 54.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 13.1 p80 . . . . . 0 N--CA 1.47 0.569 0 O-C-N 124.238 0.961 . . . . 0.0 112.527 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.463 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 50.7 t80 . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 52.9 Cg_endo -70.34 140.34 40.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.378 2.052 . . . . 0.0 111.639 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -70.82 115.57 37.22 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.43 137.1 67.71 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.53 2.154 . . . . 0.0 111.04 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' HA ' HD22 ' A' ' 8' ' ' ASN . 59.3 ttm-85 -55.99 -34.32 65.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.99 -39.54 85.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.4 m -58.83 -29.79 67.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 5' ' ' ARG . 79.8 m-20 -69.22 -46.36 67.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.96 -44.26 96.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.72 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -57.24 -45.64 83.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.186 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.46 -43.64 98.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.87 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -62.3 -48.69 78.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.517 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.38 -13.93 60.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.247 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.29 78.86 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.963 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 22.8 pt -92.81 19.82 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.791 0.805 . . . . 0.0 109.695 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.22 -43.0 98.91 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.058 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -68.9 -18.11 64.07 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.513 -0.404 . . . . 0.0 110.581 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 16.9 tptp -83.58 -35.91 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.928 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -94.71 108.07 34.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.672 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.68 -48.16 22.77 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.917 2.411 . . . . 0.0 113.571 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 4.7 p90 -69.44 -21.66 63.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.554 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 95.4 m -122.43 53.61 1.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.7 p-80 -65.89 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.307 1.004 . . . . 0.0 112.462 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -87.55 -166.92 1.72 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -59.53 146.71 39.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.634 -0.257 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.63 138.3 41.27 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.625 2.217 . . . . 0.0 112.433 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 3' ' ' ARG . 16.8 mmt180 -149.76 138.82 12.72 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 28.9 Cg_exo -61.33 142.28 95.41 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.818 2.345 . . . . 0.0 112.236 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.7 -19.19 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.704 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mt -62.95 -31.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.795 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.5 m -54.01 -31.02 49.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.771 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.76 -51.73 66.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.701 . . . . 0.0 109.736 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.26 -43.63 98.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.974 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -55.89 -48.04 76.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.047 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.6 m -65.69 -43.56 88.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 110.716 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -59.45 -44.17 93.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.186 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 -0.97 57.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 19.05 65.81 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.9 pt -92.15 20.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.771 0.796 . . . . 0.0 109.69 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -58.79 -45.77 94.43 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.802 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -67.22 -16.23 64.17 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.695 -0.297 . . . . 0.0 111.395 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.851 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -84.45 -37.35 21.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.232 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.75 109.76 34.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.46 -45.6 38.62 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.759 2.306 . . . . 0.0 113.302 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 7.3 p90 -70.71 -14.34 62.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.981 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 89.7 m -137.61 56.38 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 15.5 p-80 -67.97 56.37 0.07 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.843 0.83 . . . . 0.0 112.163 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 t -77.6 -168.99 1.32 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.08 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -72.99 -175.88 1.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.533 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.775 -0.193 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.88 132.46 26.61 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.403 2.069 . . . . 0.0 111.795 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -67.27 130.58 93.54 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.003 0.43 . . . . 0.0 110.968 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.91 139.07 83.89 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.287 2.658 . . . . 0.0 112.269 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.81 -29.84 70.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mt -63.33 -34.94 70.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.048 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.8 m -53.96 -30.08 45.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -61.08 -47.22 87.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.306 0.574 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.22 -39.49 82.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.205 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -56.25 -47.66 78.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.719 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 m -64.87 -45.13 87.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.417 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -58.34 -43.4 88.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.057 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 1.18 55.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.81 59.49 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.598 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.28 19.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.434 0.635 . . . . 0.0 110.367 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.18 -36.93 92.03 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.813 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -69.09 -27.34 65.51 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.384 -0.48 . . . . 0.0 110.589 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.47 -33.54 28.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.595 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.1 m-85 -88.59 111.61 45.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 111.664 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 17.6 Cg_endo -58.37 -45.45 30.68 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.991 2.461 . . . . 0.0 112.716 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -83.1 5.5 22.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.824 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.41 57.14 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.744 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 18.2 m-70 -73.77 54.23 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.638 0.732 . . . . 0.0 111.335 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.4 t -80.54 173.7 12.34 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.766 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -156.43 -24.44 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.068 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.397 -0.365 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.95 141.5 89.66 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.576 2.184 . . . . 0.0 111.966 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.592 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 14.3 tpt180 -152.99 120.34 3.04 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.301 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.592 ' HD2' ' HD2' ' A' ' 3' ' ' ARG . 24.0 Cg_exo -63.34 124.85 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.326 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -88.62 33.79 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.98 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.8 mm -71.35 -11.8 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.186 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.3 m -50.63 -29.29 10.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.146 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -60.61 -52.34 65.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.25 -43.15 87.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.991 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -56.5 -47.92 78.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.645 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.44 -39.57 92.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.22 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -62.91 -46.18 89.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.789 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.1 2.3 50.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.035 0.445 . . . . 0.0 111.356 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.72 61.44 Favored Glycine 0 CA--C 1.508 -0.399 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.477 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.1 pt -91.41 21.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.396 0.617 . . . . 0.0 110.116 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -59.59 -40.78 96.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.758 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -64.47 -30.6 71.63 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.358 -0.495 . . . . 0.0 110.668 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -73.51 -37.03 65.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.625 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.29 112.85 52.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 111.856 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 35.6 Cg_exo -57.9 -46.14 28.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.17 2.58 . . . . 0.0 112.812 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -78.52 0.71 25.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.112 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.1 m -150.06 61.34 0.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.724 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.1 m-70 -70.89 55.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.476 0.655 . . . . 0.0 112.263 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.8 t -76.86 -168.25 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.663 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.8 mtm-85 -61.55 160.66 10.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.526 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.813 -0.176 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 19.3 p90 . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.76 133.25 26.95 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.44 2.093 . . . . 0.0 111.928 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -90.06 142.23 28.57 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.094 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.8 140.31 67.62 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.789 2.326 . . . . 0.0 111.51 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HA ' HD22 ' A' ' 8' ' ' ASN . 16.9 ptm180 -49.87 -36.07 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.148 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 58.3 mt -72.58 -43.36 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.125 0.488 . . . . 0.0 110.959 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.64 -29.16 69.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.592 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 5' ' ' ARG . 63.2 m-20 -64.6 -48.25 75.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.24 82.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -63.61 -41.59 98.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.321 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -59.68 -47.39 85.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.259 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -88.82 3.73 50.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.918 0.39 . . . . 0.0 111.741 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.02 25.6 72.13 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.973 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 18' ' ' LYS . 9.3 mm -88.78 16.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.893 0.854 . . . . 0.0 109.346 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.37 -25.46 66.82 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.184 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -85.0 -22.92 28.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.731 0.301 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 15' ' ' ILE . 54.0 tptt -90.33 -30.91 17.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.496 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -89.7 107.99 22.46 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 30.9 Cg_exo -61.27 -40.98 45.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.581 2.187 . . . . 0.0 111.844 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.54 -3.04 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.497 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.5 m -142.69 57.64 1.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 47.0 t-80 -72.26 56.95 0.35 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.666 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 t -71.8 -175.29 1.35 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.259 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -155.59 133.05 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.514 -0.312 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.23 134.58 39.76 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.643 2.229 . . . . 0.0 111.821 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 46.3 mmm-85 -89.22 130.92 42.35 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.495 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 38.1 Cg_exo -60.0 138.07 79.81 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.067 2.511 . . . . 0.0 112.547 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 29.1 ptt-85 -61.31 -20.18 62.63 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.7 mm -59.8 -30.16 44.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.901 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -51.86 -30.64 24.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.967 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 2.4 m-80 -58.07 -50.37 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.403 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 3.3 mt -70.29 -38.64 75.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.535 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.12 -47.24 72.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.984 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.92 -44.55 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 86.8 mtt180 -62.25 -44.07 97.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.979 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.48 1.6 48.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.419 . . . . 0.0 111.102 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.66 19.88 58.72 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.993 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.535 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 23.5 pt -90.15 14.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.739 . . . . 0.0 109.97 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.77 -33.54 87.17 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.506 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -66.36 -36.25 82.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE3' ' HE1' ' A' ' 19' ' ' TYR . 38.9 ttpt -79.03 -30.84 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.183 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 3.0 m-30 -88.4 110.48 36.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.724 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 18.4 Cg_endo -58.5 -46.64 23.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.854 2.369 . . . . 0.0 112.693 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.419 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.3 p90 -75.66 -6.54 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.714 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 87.7 m -140.04 53.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 9.5 t60 -70.46 54.13 0.15 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.703 0.763 . . . . 0.0 111.449 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.3 t -78.93 178.28 8.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.444 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -73.71 -49.32 26.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.334 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.411 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 48.7 t80 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 60.8 Cg_endo -74.03 135.15 20.62 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.431 2.087 . . . . 0.0 111.697 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 14.3 ptm180 -170.95 159.68 5.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 3' ' ' ARG . 5.7 Cg_endo -48.69 136.14 27.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.509 2.806 . . . . 0.0 113.566 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -57.85 -27.45 63.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.642 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 40.0 mt -54.11 -35.91 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.055 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.1 m -54.07 -30.26 47.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -66.66 -47.26 73.07 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.3 pp -72.22 -30.41 64.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.14 -46.92 88.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.156 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -63.84 -41.48 97.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.184 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -60.36 -48.28 82.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.102 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.43 3.48 39.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.97 0.414 . . . . 0.0 111.321 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.45 19.93 60.61 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.799 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 17.9 pt -89.49 17.8 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.748 0.785 . . . . 0.0 109.972 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.66 -40.82 98.49 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.42 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -13.19 61.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.735 0.302 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -91.82 -36.33 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.832 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 m-85 -89.32 112.18 49.8 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 13.5 Cg_endo -56.85 -47.12 24.86 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.863 2.375 . . . . 0.0 112.927 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.472 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.6 p90 -75.47 -7.65 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.587 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.472 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 84.1 m -136.82 52.53 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -69.11 55.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.036 0.835 . . . . 0.0 111.385 -178.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -79.57 -178.04 6.13 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.448 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -73.4 -54.6 7.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.48 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.44 137.69 40.3 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 111.794 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 60.3 mtp85 -83.05 130.98 55.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.739 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 35.6 Cg_exo -59.09 140.55 95.66 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.656 2.238 . . . . 0.0 111.132 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.745 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 68.1 ttt180 -77.11 39.98 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.455 0.645 . . . . 0.0 111.149 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 6' ' ' ILE . 3.7 pt -72.65 -35.46 50.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -55.62 -27.79 51.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.116 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 5' ' ' ARG . 18.7 t30 -57.39 -50.39 73.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.709 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.9 -40.25 87.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.189 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.76 -48.74 72.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.636 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 m -65.3 -45.06 85.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -58.28 -44.28 88.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.345 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.2 3.06 50.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.89 18.83 57.86 Favored Glycine 0 CA--C 1.509 -0.292 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.57 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.4 pt -90.08 19.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.497 0.665 . . . . 0.0 109.933 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.46 -43.9 98.26 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.785 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -74.45 -7.42 52.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.793 0.33 . . . . 0.0 110.996 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HD2' ' HE1' ' A' ' 19' ' ' TYR . 38.8 ttmt -91.09 -39.23 12.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.045 0.45 . . . . 0.0 109.797 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' HE1' ' HD2' ' A' ' 18' ' ' LYS . 2.2 m-30 -92.77 109.96 42.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.737 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.19 -43.73 50.23 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.753 2.302 . . . . 0.0 112.864 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.55 -0.38 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.014 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.5 m -147.13 51.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.697 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -68.66 54.42 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.771 0.796 . . . . 0.0 111.868 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.1 t -79.14 173.74 12.27 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.874 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -76.31 81.22 3.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.554 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 48.9 t80 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.19 143.14 12.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.943 2.428 . . . . 0.0 111.795 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.03 149.32 5.67 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 12.2 Cg_endo -56.57 148.61 62.92 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.985 2.457 . . . . 0.0 112.753 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -56.43 -27.25 56.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.457 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.586 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 42.4 mt -60.84 -36.9 74.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' SG ' ' HG2' ' A' ' 4' ' ' PRO . 86.3 m -57.67 -28.38 63.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.93 -51.02 69.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.561 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -72.64 -30.08 64.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.355 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.72 -47.01 88.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.806 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.7 m -64.77 -41.87 95.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -59.12 -44.61 92.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.793 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 3.62 49.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.97 20.96 58.39 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.618 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 13.4 pt -89.8 20.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.266 0.555 . . . . 0.0 110.366 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.24 -37.15 93.52 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.043 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -71.03 -23.05 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.408 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 9.9 mtpm? -83.85 -34.4 24.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.691 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.6 112.35 51.25 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.998 0.428 . . . . 0.0 111.592 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.29 -45.58 33.98 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.972 2.448 . . . . 0.0 112.805 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 2.6 p90 -80.27 0.9 30.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.057 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 97.4 m -143.71 61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.7 m170 -69.38 53.07 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.491 0.662 . . . . 0.0 112.172 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.3 t -80.04 -173.17 3.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.491 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -81.11 173.65 12.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.314 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.74 -0.209 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.58 142.64 59.57 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.602 2.202 . . . . 0.0 112.071 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.8 ptp180 -168.64 142.49 2.54 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 7' ' ' CYS . 37.7 Cg_exo -57.36 146.99 80.11 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.854 2.37 . . . . 0.0 111.728 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -55.12 -33.88 63.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.442 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 46.2 mt -63.77 -37.54 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.833 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 4' ' ' PRO . 96.7 m -55.11 -28.67 54.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.418 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -64.65 -49.76 69.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -69.82 -30.92 68.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -61.22 -46.24 91.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.41 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -64.88 -42.37 94.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 4.2 tmt_? -61.14 -47.7 85.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 0.98 43.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.961 0.41 . . . . 0.0 111.35 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.7 19.06 62.42 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.656 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.0 pt -89.98 17.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.642 0.734 . . . . 0.0 109.961 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.92 -39.53 98.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.415 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -70.31 -17.68 63.08 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.719 -0.283 . . . . 0.0 110.862 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -90.35 -33.02 16.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.509 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -88.35 112.89 52.68 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.69 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 -44.02 35.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.764 2.31 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -80.5 0.03 35.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.34 56.9 1.12 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t60 -70.21 52.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -76.36 -175.97 3.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.367 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -60.63 -57.71 11.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.453 -0.34 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.47 151.07 47.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.864 2.376 . . . . 0.0 111.927 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -165.66 152.89 9.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.84 144.5 35.08 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.189 2.593 . . . . 0.0 112.941 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -60.9 -24.68 66.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.95 -35.24 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.159 0.504 . . . . 0.0 110.096 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.2 -28.98 63.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.778 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -59.96 -46.19 90.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.777 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.83 -40.67 79.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.032 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -55.5 -46.14 77.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.468 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -65.01 -43.59 91.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -59.62 -46.75 88.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.097 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.72 1.28 43.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.968 0.413 . . . . 0.0 111.005 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.09 61.09 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.746 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.6 pt -89.11 20.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.233 0.539 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.19 -30.36 73.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.71 -23.58 56.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 4.3 mmmp? -88.3 -29.6 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.541 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.87 110.24 50.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.2 -43.84 32.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.75 2.3 . . . . 0.0 112.332 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.73 2.16 27.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.597 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -145.42 55.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.607 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 39.9 t60 -71.53 53.54 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.403 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -77.32 177.28 8.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.776 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -161.55 67.16 0.28 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.042 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.375 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 5.7 m-85 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 17.2 Cg_exo -67.03 137.64 45.08 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.786 2.324 . . . . 0.0 111.89 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 ptm180 -165.64 138.64 3.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 23.0 Cg_exo -64.71 134.13 39.49 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.73 2.286 . . . . 0.0 112.121 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -68.2 -24.95 65.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.501 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.624 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 36.4 mm -59.24 -31.88 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -53.1 -29.09 28.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.413 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.31 -55.52 33.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -69.37 -30.5 68.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.307 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -60.76 -47.07 87.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.745 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.3 m -67.09 -41.17 86.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.432 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -59.69 -44.98 93.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.77 1.19 54.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.954 0.406 . . . . 0.0 111.099 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.04 63.31 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.614 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.42 20.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.457 0.646 . . . . 0.0 110.182 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.95 -31.89 80.13 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.837 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -74.11 -25.31 59.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 63.1 tttp -82.52 -34.53 27.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.549 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.08 110.47 40.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 111.678 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 31.1 Cg_exo -59.29 -43.69 39.17 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.91 2.406 . . . . 0.0 112.763 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -78.99 1.01 25.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.663 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.5 m -147.21 58.17 1.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t-160 -68.78 54.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.773 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -78.66 -169.55 1.77 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.801 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -71.06 175.14 5.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.899 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 116.691 -0.231 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 53.0 t80 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 44.3 Cg_endo -69.5 137.31 35.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.364 2.043 . . . . 0.0 111.958 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.448 HH11 ' HB2' ' A' ' 7' ' ' CYS . 4.7 tmm_? -161.23 126.69 2.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.4 126.82 21.02 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.789 2.326 . . . . 0.0 112.97 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -69.42 -19.49 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.449 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.612 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 35.8 mt -64.79 -33.42 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.657 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HB2' HH11 ' A' ' 3' ' ' ARG . 80.8 m -52.43 -30.31 28.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.367 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.14 -50.6 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -74.69 -29.86 61.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.157 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.509 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.4 -46.01 89.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.033 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.23 -42.71 93.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.545 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -60.18 -47.9 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.199 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.29 2.83 42.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 111.388 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.6 21.98 61.1 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.695 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.0 pt -92.2 16.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.628 0.728 . . . . 0.0 109.758 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.17 -45.63 95.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.426 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -15.15 62.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.454 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 24.6 mmmt -91.14 -33.84 15.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.7 m-85 -88.84 113.86 57.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.0 110.991 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 12.0 Cg_endo -56.04 -46.64 29.59 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.1 2.533 . . . . 0.0 113.076 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -79.78 1.61 26.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.004 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -146.55 57.0 1.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 5.9 m170 -69.53 53.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.527 0.679 . . . . 0.0 112.218 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.1 t -83.15 -178.64 7.17 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.138 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.6 -101.27 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.558 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.398 0 O-C-N 122.321 -0.237 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.49 149.81 84.35 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.736 2.291 . . . . 0.0 112.118 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -148.0 136.38 11.3 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.99 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.15 132.45 49.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.914 2.409 . . . . 0.0 112.665 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -65.14 -24.65 67.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -63.69 -34.94 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.582 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.9 m -54.95 -30.37 58.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -62.18 -44.91 95.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.459 0.647 . . . . 0.0 109.561 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.0 -37.74 72.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.91 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.569 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.35 -47.46 72.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.607 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -61.54 -45.23 95.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 109.984 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -60.45 -45.49 93.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.309 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.01 8.42 12.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.589 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.87 29.99 56.05 Favored Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.822 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.853 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 12.6 pt -99.61 22.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.315 0.579 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.29 -36.04 91.84 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.924 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -86.27 -15.83 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.164 0.507 . . . . 0.0 109.813 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.853 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -82.57 -39.86 21.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.811 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -96.75 111.68 58.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.237 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.58 -42.68 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.82 2.346 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -77.6 -6.0 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.7 m -133.14 55.05 1.92 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 59.8 t60 -71.25 54.68 0.2 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.076 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 t -74.0 176.0 6.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.169 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -68.84 103.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 116.445 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 41.1 t80 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 80.0 Cg_endo -77.97 178.58 7.42 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.759 2.306 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -163.88 146.22 7.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.9 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 140.0 85.49 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.651 2.234 . . . . 0.0 112.3 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.13 -17.65 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.273 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.59 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 34.5 mm -60.91 -33.03 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.782 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -53.85 -29.65 42.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.037 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -56.8 -56.45 21.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.087 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 3.9 pp -70.93 -32.92 69.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.55 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -62.39 -45.53 92.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.543 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -65.41 -46.92 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 9' ' ' LEU . 20.0 ptp180 -66.6 -37.64 85.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.24 -2.33 56.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 0.0 110.627 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.18 20.76 63.24 Favored Glycine 0 CA--C 1.508 -0.391 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.785 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.0 pt -93.41 16.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.663 0.744 . . . . 0.0 109.771 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.33 -42.66 98.92 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.783 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -62.69 -27.96 69.61 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.369 -0.489 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -80.27 -33.49 37.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -87.36 115.04 61.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 50.0 Cg_exo -56.46 -48.25 19.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.242 2.628 . . . . 0.0 113.294 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -79.28 2.32 21.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.4 m -150.0 58.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.5 m-70 -70.02 53.24 0.13 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.56 0.695 . . . . 0.0 112.28 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.8 t -77.19 -170.25 1.64 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -67.49 173.14 4.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.787 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.695 -0.229 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 8.0 m-85 . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 14.5 Cg_exo -68.66 137.94 40.19 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.935 2.423 . . . . 0.0 111.631 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -87.41 127.34 59.12 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.16 145.76 63.41 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.79 2.327 . . . . 0.0 110.891 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -50.48 -35.34 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.782 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 49.3 mm -74.27 -43.7 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 110.788 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -60.94 -28.26 68.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -57.75 -55.14 38.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.455 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -69.17 -32.14 71.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.135 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.2 -46.25 90.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.299 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.0 -45.44 81.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 110.719 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.51 -44.32 96.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.22 1.34 45.07 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.03 19.71 59.39 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.607 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 14.3 pt -89.9 20.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.405 0.621 . . . . 0.0 110.199 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.93 -36.47 92.19 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.833 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -72.46 -23.84 61.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.923 0.392 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 28.3 mtpp -83.24 -33.72 26.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -89.29 110.87 41.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 0.0 111.111 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 48.9 Cg_exo -56.66 -46.26 31.07 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.036 2.491 . . . . 0.0 112.802 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.77 -0.52 34.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.909 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.7 m -141.7 57.91 1.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 16.7 m170 -69.83 52.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.581 0.705 . . . . 0.0 111.797 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.4 t -78.19 -179.04 5.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.643 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.33 154.05 11.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.09 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 116.737 -0.21 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 29.2 p90 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 7.6 Cg_exo -71.88 132.57 20.21 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.624 2.216 . . . . 0.0 111.595 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -78.87 143.62 62.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.759 0.314 . . . . 0.0 110.658 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.32 139.08 63.84 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.732 2.288 . . . . 0.0 112.279 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -65.99 -15.07 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.0 mt -59.83 -33.75 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.369 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.7 m -56.23 -30.67 62.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.568 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.56 -42.77 99.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.209 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.4 tp -75.91 -42.27 49.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.843 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -53.21 -45.84 68.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.63 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.3 m -66.14 -48.59 70.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' LEU . 19.6 ptp180 -64.51 -36.51 84.42 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.18 1.48 52.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.047 0.451 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.77 20.78 57.43 Favored Glycine 0 CA--C 1.509 -0.322 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.002 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.7 pt -94.28 17.87 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.656 0.741 . . . . 0.0 109.486 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.16 -41.22 98.07 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.343 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -74.46 -16.4 60.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 15' ' ' ILE . 56.7 mtpt -84.01 -37.42 22.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.066 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 m-85 -94.4 107.83 32.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 9.3 Cg_endo -52.87 -46.38 34.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.353 2.702 . . . . 0.0 113.715 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -68.21 -19.64 64.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.735 0.303 . . . . 0.0 111.675 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.6 m -128.55 55.77 1.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.648 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 20.3 p-80 -68.05 54.72 0.07 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.173 0.92 . . . . 0.0 111.815 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.0 -175.99 4.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.819 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -66.26 -58.01 6.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.714 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.445 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 38.5 t80 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 5.8 Cg_exo -77.46 68.54 7.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.127 2.551 . . . . 0.0 111.911 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.3 ppt_? -72.34 145.18 87.74 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.116 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 51.1 Cg_exo -55.82 152.41 35.66 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.459 2.773 . . . . 0.0 113.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -62.6 -25.3 68.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.879 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 38.7 mt -60.49 -31.79 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.078 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.449 ' HB2' ' HD3' ' A' ' 3' ' ' ARG . 87.2 m -51.92 -28.98 18.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -58.17 -51.34 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -74.57 -30.95 61.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.007 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.79 -47.1 87.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.008 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.23 -42.23 84.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.538 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -59.83 -47.05 87.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.169 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 3.44 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.882 0.372 . . . . 0.0 111.258 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.43 21.29 59.88 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.689 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 10' ' ' ALA . 17.0 pt -91.59 16.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.612 0.72 . . . . 0.0 109.697 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.05 -43.46 99.41 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.267 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -17.46 64.54 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.745 -0.267 . . . . 0.0 111.433 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -90.75 -33.17 15.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.2 m-85 -89.21 113.94 58.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.644 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 17.7 Cg_endo -58.29 -46.24 26.12 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.952 2.435 . . . . 0.0 113.051 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -78.59 0.26 27.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 111.872 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -147.61 56.55 1.1 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.629 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.8 t60 -69.96 52.63 0.12 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.774 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -78.03 -175.76 4.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.328 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -78.19 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.687 -0.233 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 43.0 t80 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 11.3 Cg_exo -71.18 138.61 33.73 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.763 2.308 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -136.54 135.88 21.2 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.28 167.86 22.59 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.197 2.598 . . . . 0.0 112.349 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -68.91 -23.05 64.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 21.6 mt -49.59 -26.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.814 0.846 . . . . 0.0 112.116 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -51.15 -27.93 9.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -57.44 -55.1 39.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -71.86 -31.23 66.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.983 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -46.81 85.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.68 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 m -69.62 -38.12 77.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.223 0.535 . . . . 0.0 110.164 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -59.15 -45.82 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.527 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -97.37 7.12 47.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.824 0.345 . . . . 0.0 111.735 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.03 26.77 69.46 Favored Glycine 0 CA--C 1.511 -0.183 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.91 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.666 HG23 ' HD2' ' A' ' 18' ' ' LYS . 11.1 mm -88.49 10.75 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.959 0.885 . . . . 0.0 109.198 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -55.86 -41.46 83.84 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.649 -1.159 . . . . 0.0 112.113 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -18.16 63.59 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.487 -0.419 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HD2' HG23 ' A' ' 15' ' ' ILE . 99.1 mttt -91.17 -32.23 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -88.37 112.73 51.73 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 111.595 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 31.7 Cg_exo -58.63 -45.7 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.857 2.371 . . . . 0.0 112.261 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.95 -0.18 29.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 67.7 m -146.89 57.96 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.736 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.4 m-70 -72.92 55.78 0.41 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.763 0.792 . . . . 0.0 111.445 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.55 178.52 7.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.726 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -66.09 120.05 12.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.766 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 116.346 -0.388 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 154.01 55.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.907 2.405 . . . . 0.0 112.57 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -124.02 133.49 24.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.897 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 23.8 Cg_exo -62.62 146.0 95.28 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.889 2.392 . . . . 0.0 112.19 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' HD2' ' H ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -61.81 -9.7 7.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.624 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.561 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 52.3 mt -63.6 -35.79 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.263 0.554 . . . . 0.0 109.721 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m -59.92 -29.44 68.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.249 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 74.5 m-20 -62.37 -51.3 68.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.599 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -71.86 -31.07 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.315 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.48 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.617 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.0 m -64.37 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.794 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 38.1 mmt180 -62.0 -48.78 78.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.011 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.24 2.82 42.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 0.0 111.253 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.25 19.81 62.28 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.667 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 10' ' ' ALA . 18.7 pt -89.92 20.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.506 0.67 . . . . 0.0 110.059 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.25 -41.07 99.39 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.765 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -71.09 -17.68 62.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 24.7 ttmm -83.57 -37.85 22.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.588 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.67 109.34 33.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 50.8 Cg_exo -56.07 -45.57 37.39 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.799 2.333 . . . . 0.0 113.104 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 6.1 p90 -73.49 -9.36 58.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 88.1 m -136.89 54.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 13.1 p80 -66.04 55.77 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.238 0.961 . . . . 0.0 112.527 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.1 t -82.02 -171.8 3.59 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.246 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -68.34 154.77 41.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.488 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -69.22 -46.36 67.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.96 -44.26 96.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.72 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -57.24 -45.64 83.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.186 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.46 -43.64 98.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.87 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -62.3 -48.69 78.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.517 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.38 -13.93 60.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.247 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.29 78.86 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.963 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 22.8 pt -92.81 19.82 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.791 0.805 . . . . 0.0 109.695 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.22 -43.0 98.91 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.058 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -68.9 -18.11 64.07 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.513 -0.404 . . . . 0.0 110.581 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 16.9 tptp -83.58 -35.91 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.928 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -94.71 108.07 34.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.672 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.68 -48.16 22.77 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.917 2.411 . . . . 0.0 113.571 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 4.7 p90 -69.44 -21.66 63.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.554 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 95.4 m -122.43 53.61 1.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.7 p-80 . . . . . 0 N--CA 1.472 0.669 0 O-C-N 124.307 1.004 . . . . 0.0 112.462 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.5 m . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.76 -51.73 66.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.701 . . . . 0.0 109.736 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.26 -43.63 98.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.974 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -55.89 -48.04 76.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.047 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.6 m -65.69 -43.56 88.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 110.716 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -59.45 -44.17 93.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.186 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 -0.97 57.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 19.05 65.81 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.9 pt -92.15 20.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.771 0.796 . . . . 0.0 109.69 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -58.79 -45.77 94.43 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.802 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -67.22 -16.23 64.17 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.695 -0.297 . . . . 0.0 111.395 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.851 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -84.45 -37.35 21.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.232 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.75 109.76 34.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.46 -45.6 38.62 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.759 2.306 . . . . 0.0 113.302 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 7.3 p90 -70.71 -14.34 62.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.981 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 89.7 m -137.61 56.38 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 15.5 p-80 . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.843 0.83 . . . . 0.0 112.163 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 C--O 1.226 -0.166 0 CA-C-O 120.55 0.214 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -61.08 -47.22 87.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.306 0.574 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.22 -39.49 82.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.205 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -56.25 -47.66 78.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.719 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 m -64.87 -45.13 87.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.417 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -58.34 -43.4 88.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.057 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 1.18 55.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.81 59.49 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.598 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.28 19.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.434 0.635 . . . . 0.0 110.367 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.18 -36.93 92.03 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.813 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -69.09 -27.34 65.51 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.384 -0.48 . . . . 0.0 110.589 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.47 -33.54 28.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.595 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.1 m-85 -88.59 111.61 45.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 111.664 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 17.6 Cg_endo -58.37 -45.45 30.68 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.991 2.461 . . . . 0.0 112.716 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -83.1 5.5 22.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.824 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.41 57.14 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.744 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 18.2 m-70 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 121.638 0.732 . . . . 0.0 111.335 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.3 m . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 121.03 0.443 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -60.61 -52.34 65.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.25 -43.15 87.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.991 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -56.5 -47.92 78.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.645 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.44 -39.57 92.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.22 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -62.91 -46.18 89.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.789 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.1 2.3 50.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.035 0.445 . . . . 0.0 111.356 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.72 61.44 Favored Glycine 0 CA--C 1.508 -0.399 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.477 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.1 pt -91.41 21.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.396 0.617 . . . . 0.0 110.116 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -59.59 -40.78 96.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.758 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -64.47 -30.6 71.63 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.358 -0.495 . . . . 0.0 110.668 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -73.51 -37.03 65.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.625 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.29 112.85 52.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 111.856 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 35.6 Cg_exo -57.9 -46.14 28.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.17 2.58 . . . . 0.0 112.812 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -78.52 0.71 25.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.112 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.1 m -150.06 61.34 0.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.724 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.1 m-70 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.476 0.655 . . . . 0.0 112.263 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 120.802 0.334 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -64.6 -48.25 75.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.24 82.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -63.61 -41.59 98.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.321 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -59.68 -47.39 85.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.259 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -88.82 3.73 50.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.918 0.39 . . . . 0.0 111.741 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.02 25.6 72.13 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.973 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 18' ' ' LYS . 9.3 mm -88.78 16.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.893 0.854 . . . . 0.0 109.346 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.37 -25.46 66.82 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.184 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -85.0 -22.92 28.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.731 0.301 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 15' ' ' ILE . 54.0 tptt -90.33 -30.91 17.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.496 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -89.7 107.99 22.46 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 30.9 Cg_exo -61.27 -40.98 45.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.581 2.187 . . . . 0.0 111.844 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.54 -3.04 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.497 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.5 m -142.69 57.64 1.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 47.0 t-80 . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.666 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.855 0.36 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 2.4 m-80 -58.07 -50.37 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.403 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 3.3 mt -70.29 -38.64 75.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.535 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.12 -47.24 72.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.984 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.92 -44.55 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 86.8 mtt180 -62.25 -44.07 97.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.979 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.48 1.6 48.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.419 . . . . 0.0 111.102 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.66 19.88 58.72 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.993 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.535 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 23.5 pt -90.15 14.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.739 . . . . 0.0 109.97 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.77 -33.54 87.17 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.506 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -66.36 -36.25 82.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE3' ' HE1' ' A' ' 19' ' ' TYR . 38.9 ttpt -79.03 -30.84 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.183 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 3.0 m-30 -88.4 110.48 36.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.724 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 18.4 Cg_endo -58.5 -46.64 23.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.854 2.369 . . . . 0.0 112.693 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.419 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.3 p90 -75.66 -6.54 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.714 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 87.7 m -140.04 53.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 9.5 t60 . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.703 0.763 . . . . 0.0 111.449 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -66.66 -47.26 73.07 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.22 -30.41 64.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.14 -46.92 88.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.156 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -63.84 -41.48 97.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.184 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -60.36 -48.28 82.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.102 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.43 3.48 39.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.97 0.414 . . . . 0.0 111.321 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.45 19.93 60.61 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.799 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 17.9 pt -89.49 17.8 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.748 0.785 . . . . 0.0 109.972 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.66 -40.82 98.49 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.42 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -13.19 61.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.735 0.302 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -91.82 -36.33 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.832 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 m-85 -89.32 112.18 49.8 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 13.5 Cg_endo -56.85 -47.12 24.86 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.863 2.375 . . . . 0.0 112.927 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.472 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.6 p90 -75.47 -7.65 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.587 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.472 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 84.1 m -136.82 52.53 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 11.8 t-160 . . . . . 0 N--CA 1.465 0.283 0 O-C-N 124.036 0.835 . . . . 0.0 111.385 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m . . . . . 0 C--O 1.224 -0.287 0 CA-C-O 121.157 0.504 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -57.39 -50.39 73.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.709 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.9 -40.25 87.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.189 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.76 -48.74 72.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.636 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 m -65.3 -45.06 85.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -58.28 -44.28 88.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.345 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.2 3.06 50.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.89 18.83 57.86 Favored Glycine 0 CA--C 1.509 -0.292 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.57 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.4 pt -90.08 19.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.497 0.665 . . . . 0.0 109.933 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.46 -43.9 98.26 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.785 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -74.45 -7.42 52.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.793 0.33 . . . . 0.0 110.996 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HD2' ' HE1' ' A' ' 19' ' ' TYR . 38.8 ttmt -91.09 -39.23 12.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.045 0.45 . . . . 0.0 109.797 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' HE1' ' HD2' ' A' ' 18' ' ' LYS . 2.2 m-30 -92.77 109.96 42.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.737 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.19 -43.73 50.23 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.753 2.302 . . . . 0.0 112.864 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.55 -0.38 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.014 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.5 m -147.13 51.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.697 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.771 0.796 . . . . 0.0 111.868 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.956 0.407 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.93 -51.02 69.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.561 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.64 -30.08 64.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.355 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.72 -47.01 88.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.806 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.7 m -64.77 -41.87 95.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -59.12 -44.61 92.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.793 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 3.62 49.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.97 20.96 58.39 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.618 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 13.4 pt -89.8 20.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.266 0.555 . . . . 0.0 110.366 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.24 -37.15 93.52 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.043 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -71.03 -23.05 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.408 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 9.9 mtpm? -83.85 -34.4 24.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.691 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.6 112.35 51.25 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.998 0.428 . . . . 0.0 111.592 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.29 -45.58 33.98 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.972 2.448 . . . . 0.0 112.805 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 2.6 p90 -80.27 0.9 30.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.057 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 97.4 m -143.71 61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.7 m170 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.491 0.662 . . . . 0.0 112.172 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m . . . . . 0 CA--C 1.519 -0.212 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.65 -49.76 69.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.82 -30.92 68.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -61.22 -46.24 91.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.41 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -64.88 -42.37 94.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 4.2 tmt_? -61.14 -47.7 85.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 0.98 43.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.961 0.41 . . . . 0.0 111.35 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.7 19.06 62.42 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.656 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.0 pt -89.98 17.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.642 0.734 . . . . 0.0 109.961 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.92 -39.53 98.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.415 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -70.31 -17.68 63.08 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.719 -0.283 . . . . 0.0 110.862 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -90.35 -33.02 16.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.509 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -88.35 112.89 52.68 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.69 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 -44.02 35.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.764 2.31 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -80.5 0.03 35.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.34 56.9 1.12 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t60 . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.205 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.6 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -59.96 -46.19 90.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.777 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.83 -40.67 79.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.032 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -55.5 -46.14 77.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.468 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -65.01 -43.59 91.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -59.62 -46.75 88.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.097 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.72 1.28 43.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.968 0.413 . . . . 0.0 111.005 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.09 61.09 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.746 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.6 pt -89.11 20.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.233 0.539 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.19 -30.36 73.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.71 -23.58 56.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 4.3 mmmp? -88.3 -29.6 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.541 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.87 110.24 50.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.2 -43.84 32.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.75 2.3 . . . . 0.0 112.332 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.73 2.16 27.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.597 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -145.42 55.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.607 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 39.9 t60 . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.818 0.342 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.31 -55.52 33.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.37 -30.5 68.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.307 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -60.76 -47.07 87.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.745 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.3 m -67.09 -41.17 86.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.432 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -59.69 -44.98 93.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.77 1.19 54.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.954 0.406 . . . . 0.0 111.099 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.04 63.31 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.614 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.42 20.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.457 0.646 . . . . 0.0 110.182 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.95 -31.89 80.13 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.837 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -74.11 -25.31 59.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 63.1 tttp -82.52 -34.53 27.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.549 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.08 110.47 40.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 111.678 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 31.1 Cg_exo -59.29 -43.69 39.17 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.91 2.406 . . . . 0.0 112.763 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -78.99 1.01 25.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.663 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.5 m -147.21 58.17 1.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t-160 . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.773 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 120.959 0.409 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.14 -50.6 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.69 -29.86 61.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.509 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.4 -46.01 89.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.033 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.23 -42.71 93.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.545 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -60.18 -47.9 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.199 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.29 2.83 42.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 111.388 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.6 21.98 61.1 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.695 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.0 pt -92.2 16.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.628 0.728 . . . . 0.0 109.758 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.17 -45.63 95.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.426 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -15.15 62.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.454 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 24.6 mmmt -91.14 -33.84 15.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.7 m-85 -88.84 113.86 57.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.0 110.991 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 12.0 Cg_endo -56.04 -46.64 29.59 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.1 2.533 . . . . 0.0 113.076 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -79.78 1.61 26.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.004 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -146.55 57.0 1.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 5.9 m170 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.527 0.679 . . . . 0.0 112.218 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.9 m . . . . . 0 CA--C 1.517 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -62.18 -44.91 95.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.459 0.647 . . . . 0.0 109.561 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.0 -37.74 72.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.91 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.569 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.35 -47.46 72.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.607 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -61.54 -45.23 95.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 109.984 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -60.45 -45.49 93.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.309 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.01 8.42 12.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.589 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.87 29.99 56.05 Favored Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.822 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.853 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 12.6 pt -99.61 22.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.315 0.579 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.29 -36.04 91.84 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.924 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -86.27 -15.83 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.164 0.507 . . . . 0.0 109.813 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.853 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -82.57 -39.86 21.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.811 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -96.75 111.68 58.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.237 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.58 -42.68 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.82 2.346 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -77.6 -6.0 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.7 m -133.14 55.05 1.92 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 59.8 t60 . . . . . 0 C--O 1.232 0.162 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.076 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 121.1 0.476 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -56.8 -56.45 21.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.087 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 12' ' ' ARG . 3.9 pp -70.93 -32.92 69.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.55 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -62.39 -45.53 92.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.543 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -65.41 -46.92 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 9' ' ' LEU . 20.0 ptp180 -66.6 -37.64 85.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.24 -2.33 56.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 0.0 110.627 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.18 20.76 63.24 Favored Glycine 0 CA--C 1.508 -0.391 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.785 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.0 pt -93.41 16.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.663 0.744 . . . . 0.0 109.771 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.33 -42.66 98.92 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.783 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -62.69 -27.96 69.61 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.369 -0.489 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -80.27 -33.49 37.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -87.36 115.04 61.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 50.0 Cg_exo -56.46 -48.25 19.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.242 2.628 . . . . 0.0 113.294 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -79.28 2.32 21.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.4 m -150.0 58.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.5 m-70 . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 121.56 0.695 . . . . 0.0 112.28 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.921 0.391 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -57.75 -55.14 38.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.455 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.17 -32.14 71.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.135 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.2 -46.25 90.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.299 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.0 -45.44 81.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 110.719 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.51 -44.32 96.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.22 1.34 45.07 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.03 19.71 59.39 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.607 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 14.3 pt -89.9 20.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.405 0.621 . . . . 0.0 110.199 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.93 -36.47 92.19 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.833 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -72.46 -23.84 61.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.923 0.392 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 28.3 mtpp -83.24 -33.72 26.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -89.29 110.87 41.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 0.0 111.111 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 48.9 Cg_exo -56.66 -46.26 31.07 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.036 2.491 . . . . 0.0 112.802 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.77 -0.52 34.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.909 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.7 m -141.7 57.91 1.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 16.7 m170 . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.581 0.705 . . . . 0.0 111.797 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.7 m . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.102 0.477 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -61.56 -42.77 99.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.209 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.4 tp -75.91 -42.27 49.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.843 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -53.21 -45.84 68.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.63 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.3 m -66.14 -48.59 70.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' LEU . 19.6 ptp180 -64.51 -36.51 84.42 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.18 1.48 52.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.047 0.451 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.77 20.78 57.43 Favored Glycine 0 CA--C 1.509 -0.322 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.002 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.7 pt -94.28 17.87 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.656 0.741 . . . . 0.0 109.486 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.16 -41.22 98.07 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.343 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -74.46 -16.4 60.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 15' ' ' ILE . 56.7 mtpt -84.01 -37.42 22.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.066 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 m-85 -94.4 107.83 32.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 9.3 Cg_endo -52.87 -46.38 34.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.353 2.702 . . . . 0.0 113.715 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -68.21 -19.64 64.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.735 0.303 . . . . 0.0 111.675 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.6 m -128.55 55.77 1.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.648 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 20.3 p-80 . . . . . 0 N--CA 1.472 0.647 0 O-C-N 124.173 0.92 . . . . 0.0 111.815 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 87.2 m . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.734 0.302 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -58.17 -51.34 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.57 -30.95 61.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.007 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.79 -47.1 87.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.008 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.23 -42.23 84.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.538 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -59.83 -47.05 87.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.169 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 3.44 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.882 0.372 . . . . 0.0 111.258 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.43 21.29 59.88 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.689 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 10' ' ' ALA . 17.0 pt -91.59 16.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.612 0.72 . . . . 0.0 109.697 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.05 -43.46 99.41 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.267 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -17.46 64.54 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.745 -0.267 . . . . 0.0 111.433 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -90.75 -33.17 15.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.2 m-85 -89.21 113.94 58.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.644 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 17.7 Cg_endo -58.29 -46.24 26.12 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.952 2.435 . . . . 0.0 113.051 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -78.59 0.26 27.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 111.872 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -147.61 56.55 1.1 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.629 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.8 t60 . . . . . 0 N--CA 1.463 0.181 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.742 0.306 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -57.44 -55.1 39.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 pp -71.86 -31.23 66.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.983 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -46.81 85.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.68 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 m -69.62 -38.12 77.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.223 0.535 . . . . 0.0 110.164 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -59.15 -45.82 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.527 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -97.37 7.12 47.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.824 0.345 . . . . 0.0 111.735 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.03 26.77 69.46 Favored Glycine 0 CA--C 1.511 -0.183 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.91 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.666 HG23 ' HD2' ' A' ' 18' ' ' LYS . 11.1 mm -88.49 10.75 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.959 0.885 . . . . 0.0 109.198 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -55.86 -41.46 83.84 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.649 -1.159 . . . . 0.0 112.113 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -18.16 63.59 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.487 -0.419 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HD2' HG23 ' A' ' 15' ' ' ILE . 99.1 mttt -91.17 -32.23 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -88.37 112.73 51.73 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 111.595 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 31.7 Cg_exo -58.63 -45.7 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.857 2.371 . . . . 0.0 112.261 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.95 -0.18 29.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 67.7 m -146.89 57.96 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.736 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.4 m-70 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 121.763 0.792 . . . . 0.0 111.445 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 6.2 m120 -62.37 -51.3 68.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.599 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 pp -71.86 -31.07 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.315 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.48 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.617 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.0 m -64.37 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.794 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 38.1 mmt180 -62.0 -48.78 78.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.011 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.24 2.82 42.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 0.0 111.253 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.25 19.81 62.28 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.667 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 10' ' ' ALA . 18.7 pt -89.92 20.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.506 0.67 . . . . 0.0 110.059 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.25 -41.07 99.39 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.765 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -71.09 -17.68 62.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 24.7 ttmm -83.57 -37.85 22.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.588 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.67 109.34 33.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 50.8 Cg_exo -56.07 -45.57 37.39 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.799 2.333 . . . . 0.0 113.104 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 6.1 p90 -73.49 -9.36 58.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 88.1 m -136.89 54.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 13.1 p80 . . . . . 0 N--CA 1.47 0.569 0 O-C-N 124.238 0.961 . . . . 0.0 112.527 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.463 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 50.7 t80 . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 52.9 Cg_endo -70.34 140.34 40.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.378 2.052 . . . . 0.0 111.639 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.9 mtp85 -70.82 115.57 37.22 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.955 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.43 137.1 67.71 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.53 2.154 . . . . 0.0 111.04 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' HA ' HD22 ' A' ' 8' ' ' ASN . 59.3 ttm-85 -55.99 -34.32 65.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.993 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.99 -39.54 85.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.223 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 75.4 m -58.83 -29.79 67.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.93 0.395 . . . . 0.0 110.692 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 5' ' ' ARG . 79.8 m-20 -69.22 -46.36 67.58 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.1 tp -62.96 -44.26 96.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.72 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -57.24 -45.64 83.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.186 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.7 m -61.46 -43.64 98.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.87 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -62.3 -48.69 78.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.517 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.38 -13.93 60.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.374 0.607 . . . . 0.0 111.247 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.29 78.86 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.963 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 22.8 pt -92.81 19.82 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.791 0.805 . . . . 0.0 109.695 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.22 -43.0 98.91 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.058 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -68.9 -18.11 64.07 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.513 -0.404 . . . . 0.0 110.581 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 16.9 tptp -83.58 -35.91 24.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.928 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -94.71 108.07 34.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.672 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.68 -48.16 22.77 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 122.917 2.411 . . . . 0.0 113.571 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.478 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 4.7 p90 -69.44 -21.66 63.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.554 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.478 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 95.4 m -122.43 53.61 1.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.7 p-80 -65.89 58.01 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.307 1.004 . . . . 0.0 112.462 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -87.55 -166.92 1.72 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.444 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -59.53 146.71 39.58 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.634 -0.257 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.482 1.145 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.63 138.3 41.27 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.625 2.217 . . . . 0.0 112.433 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.466 ' HA ' ' HD3' ' A' ' 3' ' ' ARG . 16.8 mmt180 -149.76 138.82 12.72 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.18 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 28.9 Cg_exo -61.33 142.28 95.41 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.818 2.345 . . . . 0.0 112.236 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 67.8 ttt-85 -59.7 -19.19 48.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.704 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.5 mt -62.95 -31.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.795 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.5 m -54.01 -31.02 49.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.771 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -62.76 -51.73 66.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.573 0.701 . . . . 0.0 109.736 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.26 -43.63 98.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.974 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -55.89 -48.04 76.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.047 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.6 m -65.69 -43.56 88.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 0.0 110.716 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -59.45 -44.17 93.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.186 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 -0.97 57.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.085 0.469 . . . . 0.0 111.157 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.22 19.05 65.81 Favored Glycine 0 CA--C 1.509 -0.283 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.246 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.9 pt -92.15 20.01 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.771 0.796 . . . . 0.0 109.69 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -58.79 -45.77 94.43 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.802 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -67.22 -16.23 64.17 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.695 -0.297 . . . . 0.0 111.395 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.851 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -84.45 -37.35 21.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.232 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.75 109.76 34.61 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.684 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.46 -45.6 38.62 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.759 2.306 . . . . 0.0 113.302 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 7.3 p90 -70.71 -14.34 62.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.981 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 89.7 m -137.61 56.38 1.76 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 15.5 p-80 -67.97 56.37 0.07 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.843 0.83 . . . . 0.0 112.163 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 t -77.6 -168.99 1.32 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.08 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -72.99 -175.88 1.91 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.533 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 116.775 -0.193 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.88 132.46 26.61 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.403 2.069 . . . . 0.0 111.795 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -67.27 130.58 93.54 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.003 0.43 . . . . 0.0 110.968 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.91 139.07 83.89 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.287 2.658 . . . . 0.0 112.269 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -64.81 -29.84 70.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mt -63.33 -34.94 70.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.048 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.8 m -53.96 -30.08 45.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.167 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -61.08 -47.22 87.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.306 0.574 . . . . 0.0 110.205 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.22 -39.49 82.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.205 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -56.25 -47.66 78.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.386 -1.279 . . . . 0.0 111.719 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.2 m -64.87 -45.13 87.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.835 0.35 . . . . 0.0 110.417 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -58.34 -43.4 88.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.057 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 1.18 55.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.81 59.49 Favored Glycine 0 CA--C 1.508 -0.353 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.598 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.28 19.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.434 0.635 . . . . 0.0 110.367 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.18 -36.93 92.03 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.813 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -69.09 -27.34 65.51 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.384 -0.48 . . . . 0.0 110.589 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -82.47 -33.54 28.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.595 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.1 m-85 -88.59 111.61 45.07 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 121.028 0.442 . . . . 0.0 111.664 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 17.6 Cg_endo -58.37 -45.45 30.68 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.991 2.461 . . . . 0.0 112.716 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -83.1 5.5 22.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.824 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.41 57.14 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.744 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 18.2 m-70 -73.77 54.23 0.48 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.638 0.732 . . . . 0.0 111.335 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.4 t -80.54 173.7 12.34 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.766 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -156.43 -24.44 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.068 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.397 -0.365 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.95 141.5 89.66 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.576 2.184 . . . . 0.0 111.966 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.592 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 14.3 tpt180 -152.99 120.34 3.04 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.301 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.592 ' HD2' ' HD2' ' A' ' 3' ' ' ARG . 24.0 Cg_exo -63.34 124.85 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.326 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -88.62 33.79 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.98 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.8 mm -71.35 -11.8 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.186 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.3 m -50.63 -29.29 10.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.146 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -60.61 -52.34 65.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.087 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.25 -43.15 87.35 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.991 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -56.5 -47.92 78.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.645 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.44 -39.57 92.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.22 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -62.91 -46.18 89.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.789 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.1 2.3 50.23 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.035 0.445 . . . . 0.0 111.356 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.72 61.44 Favored Glycine 0 CA--C 1.508 -0.399 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.477 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.52 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.1 pt -91.41 21.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.396 0.617 . . . . 0.0 110.116 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -59.59 -40.78 96.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.758 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -64.47 -30.6 71.63 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.358 -0.495 . . . . 0.0 110.668 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -73.51 -37.03 65.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.625 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.29 112.85 52.35 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.207 0.527 . . . . 0.0 111.856 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' HA ' ' CE1' ' A' ' 23' ' ' HIS . 35.6 Cg_exo -57.9 -46.14 28.05 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.17 2.58 . . . . 0.0 112.812 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -78.52 0.71 25.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 112.112 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.1 m -150.06 61.34 0.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.724 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.1 m-70 -70.89 55.24 0.17 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.476 0.655 . . . . 0.0 112.263 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.8 t -76.86 -168.25 1.01 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.663 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 61.8 mtm-85 -61.55 160.66 10.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.526 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 116.813 -0.176 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 19.3 p90 . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.76 133.25 26.95 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.44 2.093 . . . . 0.0 111.928 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -90.06 142.23 28.57 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.094 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.8 140.31 67.62 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.789 2.326 . . . . 0.0 111.51 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HA ' HD22 ' A' ' 8' ' ' ASN . 16.9 ptm180 -49.87 -36.07 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.148 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 58.3 mt -72.58 -43.36 62.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.125 0.488 . . . . 0.0 110.959 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.8 m -61.64 -29.16 69.88 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.592 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 5' ' ' ARG . 63.2 m-20 -64.6 -48.25 75.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.844 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -70.28 -31.69 69.16 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.24 82.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.589 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -63.61 -41.59 98.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.897 0.38 . . . . 0.0 110.321 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -59.68 -47.39 85.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.259 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -88.82 3.73 50.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.918 0.39 . . . . 0.0 111.741 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.02 25.6 72.13 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.973 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.587 HG22 ' HB3' ' A' ' 18' ' ' LYS . 9.3 mm -88.78 16.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.893 0.854 . . . . 0.0 109.346 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.37 -25.46 66.82 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.184 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -85.0 -22.92 28.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.731 0.301 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 15' ' ' ILE . 54.0 tptt -90.33 -30.91 17.16 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.496 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -89.7 107.99 22.46 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.39 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 30.9 Cg_exo -61.27 -40.98 45.5 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.581 2.187 . . . . 0.0 111.844 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -78.54 -3.04 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.497 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.5 m -142.69 57.64 1.43 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.61 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 47.0 t-80 -72.26 56.95 0.35 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.666 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.1 t -71.8 -175.29 1.35 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.259 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -155.59 133.05 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.514 -0.312 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -65.23 134.58 39.76 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.643 2.229 . . . . 0.0 111.821 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.467 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 46.3 mmm-85 -89.22 130.92 42.35 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.495 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 38.1 Cg_exo -60.0 138.07 79.81 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 123.067 2.511 . . . . 0.0 112.547 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 29.1 ptt-85 -61.31 -20.18 62.63 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.772 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.7 mm -59.8 -30.16 44.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.901 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 88.5 m -51.86 -30.64 24.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.967 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 12' ' ' ARG . 2.4 m-80 -58.07 -50.37 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.403 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 9' ' ' LEU . 3.3 mt -70.29 -38.64 75.05 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.535 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.12 -47.24 72.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.984 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.1 m -66.92 -44.55 80.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.082 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 8' ' ' ASN . 86.8 mtt180 -62.25 -44.07 97.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.979 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.48 1.6 48.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.979 0.419 . . . . 0.0 111.102 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.66 19.88 58.72 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.993 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.535 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 23.5 pt -90.15 14.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.651 0.739 . . . . 0.0 109.97 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.77 -33.54 87.17 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.506 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -66.36 -36.25 82.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.948 0.404 . . . . 0.0 110.761 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HE3' ' HE1' ' A' ' 19' ' ' TYR . 38.9 ttpt -79.03 -30.84 44.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.183 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' HE1' ' HE3' ' A' ' 18' ' ' LYS . 3.0 m-30 -88.4 110.48 36.82 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.949 0.404 . . . . 0.0 111.724 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 18.4 Cg_endo -58.5 -46.64 23.07 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.854 2.369 . . . . 0.0 112.693 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.419 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.3 p90 -75.66 -6.54 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.714 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 87.7 m -140.04 53.28 1.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.719 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 9.5 t60 -70.46 54.13 0.15 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.703 0.763 . . . . 0.0 111.449 -178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.3 t -78.93 178.28 8.11 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.444 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -73.71 -49.32 26.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.334 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.411 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 48.7 t80 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 60.8 Cg_endo -74.03 135.15 20.62 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.431 2.087 . . . . 0.0 111.697 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.537 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 14.3 ptm180 -170.95 159.68 5.49 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 3' ' ' ARG . 5.7 Cg_endo -48.69 136.14 27.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.509 2.806 . . . . 0.0 113.566 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -57.85 -27.45 63.22 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.642 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 40.0 mt -54.11 -35.91 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.055 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.1 m -54.07 -30.26 47.47 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -66.66 -47.26 73.07 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.088 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.3 pp -72.22 -30.41 64.88 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.14 -46.92 88.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.156 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.0 m -63.84 -41.48 97.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.184 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.0 tpp180 -60.36 -48.28 82.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.102 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.43 3.48 39.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.97 0.414 . . . . 0.0 111.321 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.45 19.93 60.61 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.799 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 17.9 pt -89.49 17.8 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 121.748 0.785 . . . . 0.0 109.972 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.66 -40.82 98.49 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.42 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -70.68 -13.19 61.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.735 0.302 . . . . 0.0 111.559 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -91.82 -36.33 13.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.832 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.3 m-85 -89.32 112.18 49.8 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.376 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 13.5 Cg_endo -56.85 -47.12 24.86 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.863 2.375 . . . . 0.0 112.927 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.472 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 5.6 p90 -75.47 -7.65 54.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.587 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.472 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 84.1 m -136.82 52.53 1.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 11.8 t-160 -69.11 55.62 0.1 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 124.036 0.835 . . . . 0.0 111.385 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.7 t -79.57 -178.04 6.13 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.448 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -73.4 -54.6 7.91 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.48 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.44 137.69 40.3 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.657 2.238 . . . . 0.0 111.794 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 60.3 mtp85 -83.05 130.98 55.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.739 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 35.6 Cg_exo -59.09 140.55 95.66 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.656 2.238 . . . . 0.0 111.132 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.745 ' HG2' ' HB2' ' A' ' 8' ' ' ASN . 68.1 ttt180 -77.11 39.98 0.25 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.455 0.645 . . . . 0.0 111.149 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' H ' HG12 ' A' ' 6' ' ' ILE . 3.7 pt -72.65 -35.46 50.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.544 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 94.5 m -55.62 -27.79 51.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.116 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 5' ' ' ARG . 18.7 t30 -57.39 -50.39 73.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.709 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.9 -40.25 87.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.189 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.76 -48.74 72.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.636 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 m -65.3 -45.06 85.88 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.33 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.6 tpt85 -58.28 -44.28 88.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.345 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.2 3.06 50.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.816 0.341 . . . . 0.0 111.176 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.89 18.83 57.86 Favored Glycine 0 CA--C 1.509 -0.292 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.57 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.4 pt -90.08 19.17 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.497 0.665 . . . . 0.0 109.933 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.46 -43.9 98.26 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.785 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -74.45 -7.42 52.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.793 0.33 . . . . 0.0 110.996 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HD2' ' HE1' ' A' ' 19' ' ' TYR . 38.8 ttmt -91.09 -39.23 12.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.045 0.45 . . . . 0.0 109.797 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' HE1' ' HD2' ' A' ' 18' ' ' LYS . 2.2 m-30 -92.77 109.96 42.35 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.737 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.19 -43.73 50.23 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.753 2.302 . . . . 0.0 112.864 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -75.55 -0.38 20.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.014 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 32.5 m -147.13 51.46 1.08 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.697 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -68.66 54.42 0.08 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.771 0.796 . . . . 0.0 111.868 -179.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 25.1 t -79.14 173.74 12.27 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.874 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 54.7 ttt-85 -76.31 81.22 3.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.554 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 48.9 t80 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.19 143.14 12.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.943 2.428 . . . . 0.0 111.795 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.03 149.32 5.67 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' HG2' ' SG ' ' A' ' 7' ' ' CYS . 12.2 Cg_endo -56.57 148.61 62.92 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.985 2.457 . . . . 0.0 112.753 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.1 tpt180 -56.43 -27.25 56.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.457 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.586 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 42.4 mt -60.84 -36.9 74.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' SG ' ' HG2' ' A' ' 4' ' ' PRO . 86.3 m -57.67 -28.38 63.73 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -61.93 -51.02 69.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.561 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -72.64 -30.08 64.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.355 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.72 -47.01 88.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.806 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.7 m -64.77 -41.87 95.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.487 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -59.12 -44.61 92.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.793 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.56 3.62 49.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 0.0 111.239 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.97 20.96 58.39 Favored Glycine 0 CA--C 1.508 -0.361 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.618 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 13.4 pt -89.8 20.74 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.266 0.555 . . . . 0.0 110.366 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.24 -37.15 93.52 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.043 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -71.03 -23.05 62.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.955 0.407 . . . . 0.0 110.408 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 9.9 mtpm? -83.85 -34.4 24.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.691 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -89.6 112.35 51.25 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.998 0.428 . . . . 0.0 111.592 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.29 -45.58 33.98 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.972 2.448 . . . . 0.0 112.805 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 2.6 p90 -80.27 0.9 30.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.057 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 97.4 m -143.71 61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.506 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 21.7 m170 -69.38 53.07 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.491 0.662 . . . . 0.0 112.172 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.3 t -80.04 -173.17 3.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.491 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -81.11 173.65 12.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.314 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.74 -0.209 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.58 142.64 59.57 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.602 2.202 . . . . 0.0 112.071 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 7.8 ptp180 -168.64 142.49 2.54 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.648 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 7' ' ' CYS . 37.7 Cg_exo -57.36 146.99 80.11 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.854 2.37 . . . . 0.0 111.728 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -55.12 -33.88 63.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.442 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 46.2 mt -63.77 -37.54 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.833 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 4' ' ' PRO . 96.7 m -55.11 -28.67 54.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.418 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.65 -49.76 69.73 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.882 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -69.82 -30.92 68.55 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -61.22 -46.24 91.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.41 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -64.88 -42.37 94.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.436 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' C ' ' HD3' ' A' ' 12' ' ' ARG . 4.2 tmt_? -61.14 -47.7 85.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.611 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.39 0.98 43.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.961 0.41 . . . . 0.0 111.35 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.7 19.06 62.42 Favored Glycine 0 CA--C 1.508 -0.346 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.656 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.0 pt -89.98 17.85 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.642 0.734 . . . . 0.0 109.961 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -62.92 -39.53 98.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.415 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -70.31 -17.68 63.08 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.719 -0.283 . . . . 0.0 110.862 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -90.35 -33.02 16.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.509 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -88.35 112.89 52.68 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.69 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.57 -44.02 35.15 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.764 2.31 . . . . 0.0 112.426 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -80.5 0.03 35.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.857 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 60.6 m -147.34 56.9 1.12 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t60 -70.21 52.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.1 t -76.36 -175.97 3.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.367 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -60.63 -57.71 11.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.72 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 116.453 -0.34 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.47 151.07 47.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.864 2.376 . . . . 0.0 111.927 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -165.66 152.89 9.34 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.84 144.5 35.08 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.189 2.593 . . . . 0.0 112.941 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -60.9 -24.68 66.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 53.6 mt -59.95 -35.24 59.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.159 0.504 . . . . 0.0 110.096 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.2 -28.98 63.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.778 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -59.96 -46.19 90.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.777 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.83 -40.67 79.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.032 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -55.5 -46.14 77.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.468 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 m -65.01 -43.59 91.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.715 0.293 . . . . 0.0 110.514 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.3 mtp85 -59.62 -46.75 88.04 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.097 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.72 1.28 43.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.968 0.413 . . . . 0.0 111.005 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.53 22.09 61.09 Favored Glycine 0 CA--C 1.508 -0.363 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.746 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.521 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 15.6 pt -89.11 20.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.233 0.539 . . . . 0.0 110.582 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.607 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.19 -30.36 73.63 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.53 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -75.71 -23.58 56.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 4.3 mmmp? -88.3 -29.6 20.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.541 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -95.87 110.24 50.58 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.2 -43.84 32.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.75 2.3 . . . . 0.0 112.332 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.73 2.16 27.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.597 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.3 m -145.42 55.72 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.607 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 39.9 t60 -71.53 53.54 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.403 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.2 t -77.32 177.28 8.06 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.776 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 57.1 ttp85 -161.55 67.16 0.28 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.042 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.375 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 5.7 m-85 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 17.2 Cg_exo -67.03 137.64 45.08 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.786 2.324 . . . . 0.0 111.89 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 ptm180 -165.64 138.64 3.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 23.0 Cg_exo -64.71 134.13 39.49 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.73 2.286 . . . . 0.0 112.121 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -68.2 -24.95 65.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.501 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.624 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 36.4 mm -59.24 -31.88 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -53.1 -29.09 28.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.413 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.31 -55.52 33.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -69.37 -30.5 68.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.307 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -60.76 -47.07 87.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.745 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.3 m -67.09 -41.17 86.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 110.432 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -59.69 -44.98 93.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.933 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.77 1.19 54.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.954 0.406 . . . . 0.0 111.099 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.6 20.04 63.31 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.614 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 10' ' ' ALA . 15.3 pt -89.42 20.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.457 0.646 . . . . 0.0 110.182 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.95 -31.89 80.13 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.837 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -74.11 -25.31 59.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.832 0.349 . . . . 0.0 110.664 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 63.1 tttp -82.52 -34.53 27.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.549 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.08 110.47 40.42 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.796 0.331 . . . . 0.0 111.678 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 31.1 Cg_exo -59.29 -43.69 39.17 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.91 2.406 . . . . 0.0 112.763 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -78.99 1.01 25.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.663 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 77.5 m -147.21 58.17 1.15 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 12.6 t-160 -68.78 54.17 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.773 -178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.8 t -78.66 -169.55 1.77 Allowed 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.801 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -71.06 175.14 5.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.899 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 116.691 -0.231 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 53.0 t80 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 44.3 Cg_endo -69.5 137.31 35.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.364 2.043 . . . . 0.0 111.958 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.448 HH11 ' HB2' ' A' ' 7' ' ' CYS . 4.7 tmm_? -161.23 126.69 2.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.4 126.82 21.02 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.789 2.326 . . . . 0.0 112.97 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -69.42 -19.49 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.449 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.612 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 35.8 mt -64.79 -33.42 63.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.657 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HB2' HH11 ' A' ' 3' ' ' ARG . 80.8 m -52.43 -30.31 28.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.367 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.14 -50.6 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -74.69 -29.86 61.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.157 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.509 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.4 -46.01 89.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.033 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.23 -42.71 93.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.545 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -60.18 -47.9 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.199 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.29 2.83 42.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.918 0.389 . . . . 0.0 111.388 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.6 21.98 61.1 Favored Glycine 0 CA--C 1.509 -0.324 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.695 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 10' ' ' ALA . 19.0 pt -92.2 16.58 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.628 0.728 . . . . 0.0 109.758 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.17 -45.63 95.68 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.426 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.66 -15.15 62.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.781 0.324 . . . . 0.0 111.454 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 24.6 mmmt -91.14 -33.84 15.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.453 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 2.7 m-85 -88.84 113.86 57.62 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.0 110.991 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 12.0 Cg_endo -56.04 -46.64 29.59 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 123.1 2.533 . . . . 0.0 113.076 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -79.78 1.61 26.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.004 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -146.55 57.0 1.17 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 5.9 m170 -69.53 53.83 0.11 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.527 0.679 . . . . 0.0 112.218 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.1 t -83.15 -178.64 7.17 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.138 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -78.6 -101.27 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.558 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.398 0 O-C-N 122.321 -0.237 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.49 149.81 84.35 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.736 2.291 . . . . 0.0 112.118 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -148.0 136.38 11.3 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.99 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.15 132.45 49.28 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.914 2.409 . . . . 0.0 112.665 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -65.14 -24.65 67.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.736 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.6 mt -63.69 -34.94 70.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.582 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.9 m -54.95 -30.37 58.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.085 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -62.18 -44.91 95.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.459 0.647 . . . . 0.0 109.561 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.0 -37.74 72.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.107 -0.952 . . . . 0.0 108.91 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.569 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -54.35 -47.46 72.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.607 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.4 m -61.54 -45.23 95.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 109.984 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -60.45 -45.49 93.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.309 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.01 8.42 12.83 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 0.0 111.589 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.87 29.99 56.05 Favored Glycine 0 CA--C 1.505 -0.557 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.822 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.853 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 12.6 pt -99.61 22.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.315 0.579 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.29 -36.04 91.84 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.924 178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -86.27 -15.83 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.164 0.507 . . . . 0.0 109.813 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.853 ' HD3' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -82.57 -39.86 21.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.811 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -96.75 111.68 58.09 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.237 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.58 -42.68 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.82 2.346 . . . . 0.0 112.47 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -77.6 -6.0 52.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.7 m -133.14 55.05 1.92 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 59.8 t60 -71.25 54.68 0.2 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.076 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 9.8 t -74.0 176.0 6.88 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.169 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.7 ttt85 -68.84 103.28 1.75 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.487 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 116.445 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' CD1' ' HD2' ' A' ' 2' ' ' PRO . 41.1 t80 . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.462 ' HD2' ' CD1' ' A' ' 1' ' ' PHE . 80.0 Cg_endo -77.97 178.58 7.42 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.759 2.306 . . . . 0.0 112.151 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -163.88 146.22 7.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.9 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.4 140.0 85.49 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.651 2.234 . . . . 0.0 112.3 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -64.13 -17.65 63.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.273 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.59 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 34.5 mm -60.91 -33.03 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.782 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.9 m -53.85 -29.65 42.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.037 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -56.8 -56.45 21.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.087 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 3.9 pp -70.93 -32.92 69.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.55 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -62.39 -45.53 92.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.543 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 97.2 m -65.41 -46.92 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 9' ' ' LEU . 20.0 ptp180 -66.6 -37.64 85.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.24 -2.33 56.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.252 0.549 . . . . 0.0 110.627 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.18 20.76 63.24 Favored Glycine 0 CA--C 1.508 -0.391 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.785 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 10' ' ' ALA . 16.0 pt -93.41 16.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.663 0.744 . . . . 0.0 109.771 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.702 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.33 -42.66 98.92 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.783 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -62.69 -27.96 69.61 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.369 -0.489 . . . . 0.0 110.775 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -80.27 -33.49 37.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.812 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -87.36 115.04 61.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.153 0.501 . . . . 0.0 111.843 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 50.0 Cg_exo -56.46 -48.25 19.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.242 2.628 . . . . 0.0 113.294 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -79.28 2.32 21.76 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 88.4 m -150.0 58.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.702 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.5 m-70 -70.02 53.24 0.13 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.56 0.695 . . . . 0.0 112.28 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.8 t -77.19 -170.25 1.64 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.967 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -67.49 173.14 4.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.787 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.695 -0.229 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 8.0 m-85 . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 14.5 Cg_exo -68.66 137.94 40.19 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.935 2.423 . . . . 0.0 111.631 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 73.9 mtt85 -87.41 127.34 59.12 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.669 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.16 145.76 63.41 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.79 2.327 . . . . 0.0 110.891 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -50.48 -35.34 28.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.782 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.593 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 49.3 mm -74.27 -43.7 49.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.134 0.492 . . . . 0.0 110.788 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.5 m -60.94 -28.26 68.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -57.75 -55.14 38.66 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.455 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -69.17 -32.14 71.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.135 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -60.2 -46.25 90.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.299 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -66.0 -45.44 81.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.802 0.334 . . . . 0.0 110.719 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.51 -44.32 96.15 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.072 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.22 1.34 45.07 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.997 0.427 . . . . 0.0 111.023 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.03 19.71 59.39 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.607 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.5 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 14.3 pt -89.9 20.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.405 0.621 . . . . 0.0 110.199 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.93 -36.47 92.19 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.833 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -72.46 -23.84 61.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.923 0.392 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 28.3 mtpp -83.24 -33.72 26.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.639 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -89.29 110.87 41.77 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-O 120.792 0.329 . . . . 0.0 111.111 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 48.9 Cg_exo -56.66 -46.26 31.07 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.036 2.491 . . . . 0.0 112.802 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.77 -0.52 34.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.909 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.7 m -141.7 57.91 1.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.624 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 16.7 m170 -69.83 52.57 0.12 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.581 0.705 . . . . 0.0 111.797 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.4 t -78.19 -179.04 5.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.643 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -165.33 154.05 11.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.09 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 116.737 -0.21 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 29.2 p90 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 7.6 Cg_exo -71.88 132.57 20.21 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.624 2.216 . . . . 0.0 111.595 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -78.87 143.62 62.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 120.759 0.314 . . . . 0.0 110.658 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.32 139.08 63.84 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.732 2.288 . . . . 0.0 112.279 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -65.99 -15.07 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.0 mt -59.83 -33.75 53.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.369 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 91.7 m -56.23 -30.67 62.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.568 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -61.56 -42.77 99.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.209 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 33.4 tp -75.91 -42.27 49.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.843 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . . . -53.21 -45.84 68.82 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.63 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.3 m -66.14 -48.59 70.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' LEU . 19.6 ptp180 -64.51 -36.51 84.42 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.18 1.48 52.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.047 0.451 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.77 20.78 57.43 Favored Glycine 0 CA--C 1.509 -0.322 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.002 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.577 ' CG1' ' HA ' ' A' ' 10' ' ' ALA . 24.7 pt -94.28 17.87 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.656 0.741 . . . . 0.0 109.486 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -60.16 -41.22 98.07 Favored Glycine 0 C--O 1.222 -0.617 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.343 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.1 m-70 -74.46 -16.4 60.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.77 0.319 . . . . 0.0 111.296 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' HD3' HG22 ' A' ' 15' ' ' ILE . 56.7 mtpt -84.01 -37.42 22.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.066 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 m-85 -94.4 107.83 32.25 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 9.3 Cg_endo -52.87 -46.38 34.13 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.353 2.702 . . . . 0.0 113.715 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -68.21 -19.64 64.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.735 0.303 . . . . 0.0 111.675 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.6 m -128.55 55.77 1.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.648 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 20.3 p-80 -68.05 54.72 0.07 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.173 0.92 . . . . 0.0 111.815 -179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.1 t -78.0 -175.99 4.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.819 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -66.26 -58.01 6.29 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.714 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.445 -0.343 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 38.5 t80 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 5.8 Cg_exo -77.46 68.54 7.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.127 2.551 . . . . 0.0 111.911 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 3' ' ' ARG . 7.3 ppt_? -72.34 145.18 87.74 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.116 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 51.1 Cg_exo -55.82 152.41 35.66 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.459 2.773 . . . . 0.0 113.66 -179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 28.6 ptt-85 -62.6 -25.3 68.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.879 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.625 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 38.7 mt -60.49 -31.79 49.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.078 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.449 ' HB2' ' HD3' ' A' ' 3' ' ' ARG . 87.2 m -51.92 -28.98 18.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.595 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -58.17 -51.34 70.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.704 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -74.57 -30.95 61.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.007 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.79 -47.1 87.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.008 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.23 -42.23 84.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.538 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -59.83 -47.05 87.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.169 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 3.44 46.36 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.882 0.372 . . . . 0.0 111.258 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.43 21.29 59.88 Favored Glycine 0 CA--C 1.51 -0.271 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.689 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 10' ' ' ALA . 17.0 pt -91.59 16.37 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.612 0.72 . . . . 0.0 109.697 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.05 -43.46 99.41 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.267 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -17.46 64.54 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 122.745 -0.267 . . . . 0.0 111.433 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -90.75 -33.17 15.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 3.2 m-85 -89.21 113.94 58.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.644 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 19' ' ' TYR . 17.7 Cg_endo -58.29 -46.24 26.12 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.952 2.435 . . . . 0.0 113.051 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -78.59 0.26 27.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.787 0.327 . . . . 0.0 111.872 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -147.61 56.55 1.1 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.629 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 27.8 t60 -69.96 52.63 0.12 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.774 -178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -78.03 -175.76 4.21 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.328 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -78.19 -91.9 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.687 -0.233 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 43.0 t80 . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 1' ' ' PHE . 11.3 Cg_exo -71.18 138.61 33.73 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.763 2.308 . . . . 0.0 111.31 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 38.0 mtm105 -136.54 135.88 21.2 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.28 167.86 22.59 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.197 2.598 . . . . 0.0 112.349 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -68.91 -23.05 64.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 21.6 mt -49.59 -26.57 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.814 0.846 . . . . 0.0 112.116 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.0 m -51.15 -27.93 9.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -57.44 -55.1 39.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.1 pp -71.86 -31.23 66.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.983 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -46.81 85.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.68 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 m -69.62 -38.12 77.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.223 0.535 . . . . 0.0 110.164 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -59.15 -45.82 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.527 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB3' HG12 ' A' ' 15' ' ' ILE . . . -97.37 7.12 47.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.824 0.345 . . . . 0.0 111.735 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.03 26.77 69.46 Favored Glycine 0 CA--C 1.511 -0.183 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.91 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.666 HG23 ' HD2' ' A' ' 18' ' ' LYS . 11.1 mm -88.49 10.75 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.959 0.885 . . . . 0.0 109.198 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.736 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -55.86 -41.46 83.84 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 114.649 -1.159 . . . . 0.0 112.113 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -18.16 63.59 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.487 -0.419 . . . . 0.0 112.049 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HD2' HG23 ' A' ' 15' ' ' ILE . 99.1 mttt -91.17 -32.23 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -88.37 112.73 51.73 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 111.595 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HA ' ' NE2' ' A' ' 23' ' ' HIS . 31.7 Cg_exo -58.63 -45.7 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.857 2.371 . . . . 0.0 112.261 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -78.95 -0.18 29.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.951 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 67.7 m -146.89 57.96 1.17 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.736 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 17.4 m-70 -72.92 55.78 0.41 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.763 0.792 . . . . 0.0 111.445 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.0 t -78.55 178.52 7.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.726 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.8 ptt85 -66.09 120.05 12.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.766 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 116.346 -0.388 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 154.01 55.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.907 2.405 . . . . 0.0 112.57 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -124.02 133.49 24.7 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.897 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 3' ' ' ARG . 23.8 Cg_exo -62.62 146.0 95.28 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.889 2.392 . . . . 0.0 112.19 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' HD2' ' H ' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -61.81 -9.7 7.27 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.624 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.561 ' O ' ' HG ' ' A' ' 9' ' ' LEU . 52.3 mt -63.6 -35.79 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.263 0.554 . . . . 0.0 109.721 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 96.7 m -59.92 -29.44 68.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.249 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 12' ' ' ARG . 6.2 m120 -62.37 -51.3 68.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.599 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 4.0 pp -71.86 -31.07 66.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.315 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HA ' HG13 ' A' ' 15' ' ' ILE . . . -59.48 -47.67 84.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.617 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.0 m -64.37 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.794 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 8' ' ' ASN . 38.1 mmt180 -62.0 -48.78 78.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.011 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.24 2.82 42.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.972 0.415 . . . . 0.0 111.253 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.25 19.81 62.28 Favored Glycine 0 CA--C 1.509 -0.34 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.667 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.488 HG13 ' HA ' ' A' ' 10' ' ' ALA . 18.7 pt -89.92 20.27 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.506 0.67 . . . . 0.0 110.059 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 23' ' ' HIS . . . -61.25 -41.07 99.39 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.765 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -71.09 -17.68 62.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.805 0.336 . . . . 0.0 110.83 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 24.7 ttmm -83.57 -37.85 22.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.588 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -90.67 109.34 33.73 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.929 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 18' ' ' LYS . 50.8 Cg_exo -56.07 -45.57 37.39 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.799 2.333 . . . . 0.0 113.104 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.403 ' HD1' ' SG ' ' A' ' 22' ' ' CYS . 6.1 p90 -73.49 -9.36 58.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' SG ' ' HD1' ' A' ' 21' ' ' PHE . 88.1 m -136.89 54.36 1.87 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 13.1 p80 -66.04 55.77 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.238 0.961 . . . . 0.0 112.527 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.1 t -82.02 -171.8 3.59 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.246 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -68.34 154.77 41.12 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.488 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.734 -0.212 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_